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In this study a novel active non-intrusive system identification paradigm is developed 
for the purpose of cardiovascular health monitoring. The proposed approach seeks to 
utilize a collocated actuator sensor unit devised from the common blood pressure cuff 
to simultaneously 1) produce rich transmural blood pressure waves that propagate 
through the cardiovascular system and 2) to make measurements of these rich 
peripheral transmural blood pressures utilizing the pressure oscillations produced 
within the cuffs bladder in order to reproduce the central aortic blood pressure 
accurately. To achieve this end a mathematical model of the cardiovascular system is 
developed to model the wave propagation dynamics of the external (excitation 
applied by the cuff) and internal (excitation produced by the heart) blood pressure 
waveforms through the cardiovascular system. Next a system identification protocol 
is developed in which rich transmural blood pressures are recorded and used to 
identify the parameters characterizing the model. The peripheral blood pressures are 
used in tandem with the characterized model to reconstruct the central aortic blood 
pressure waveform. The results of this study indicate the developed protocol can 
reliably and accurately reproduced the central aortic blood pressure and that it can 
outperform its intrusive passive counterpart (the Individualized Transfer Function 
methodology). The root-mean-square error in waveform reproduction, pulse pressure 
error and systolic pressure errors were evaluated to be 3.31 mmHg, 1.36 mmHg and 
0.06 mmHg respectively for the active nonintrusive methodology while for the 
passive intrusive counterpart the same errors were evaluated to be 4.12 mmHg, 1.59 
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Chapter 1 - Importance of Cardiovascular Disease Diagnosis 
and Prevention 
1.1: Importance of Cardiovascular Disease in Modern Day Society 
Cardiovascular Disease (CVD) is one of the most prevalent sources of morbidity and 
mortality in modern times. The World Health Organization estimates that CVD is 
responsible for approximate 1 in 3 deaths worldwide [1] and billions of dollars are 
spent in direct costs [2]. The American Heart Association (AHA) [3] reports that 
CVDs are responsible for 1 in every 3 deaths (32.8%) in the United States (which is 
approximately 1 death every 39 seconds) and that CVDs have extremely high impacts 
on society in general. During the decade between 1999 and 2009 the number of 
procedures associated with CVDs has increased by 22% and indicates a growing and 
ever more prevalent problem. In addition to this increase in the number of CVD, the 
healthcare cost associated with this category of diseases is higher than any other 
diagnostics group which compounds the problem of treatment and increases burden 
on resources available. Prevention of CVDs, including early identification and 
treatment, can save billions, for example the healthcare cost of CVDs, strokes and 
related conditions was approximately $300 billion dollars, compared to the $228 
billion associated with cancers. 
Hypertension, a very common type of CVD, is defined as a patient having systolic 
blood pressure of above 140 mmHg and/or diastolic blood pressure above 90 mmHg. 
Hypertension is well-known and widely accepted as a risk factor of CVDs [4] and 
astonishingly approximately 76,400,000 out of approximately 82,600,000 adult 
Americans having CVDs suffer from hypertension. Of these hypertensive individuals 
approximately 4 out of 5 are aware of the fact that they suffer from hypertension and 
1 in 5 do not even have knowledge of this very important risk factor. Of these 
individuals 75% are under current treatment, but unfortunately, only 53% have it 
controlled with the remaining 47% having it uncontrolled [3].  In addition, 
hypertension is much more prevalent in the elderly population (more than 50% in 
individuals with age>55, which further complicates and emphasizes the seriousness 
of CVD since the older population has higher chances of having other health 
problems in addition to CVD.  Further, the rate of death from hypertension as well as 
the actual number of deaths is estimated to have been increasing, with the resulting 
healthcare cost of ~$51 billion in 2009.  Considering the tremendous impact of CVD 
on the quality of life, it is imperative to develop a systematic method that is readily 
accessible to assess hypertension and CVD to closely monitor CV health, promptly 
detect CVD, and effectively manage CVD risk factors and parameters. 
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1.2: Techniques for Monitoring of Cardiovascular Health: State of the 
Art and Shortcomings 
Blood pressure in the arterial tree is produced by the pressure differential across the 
left ventricle of the heart. Blood pressure waveforms are lateral waveforms that 
propagate along the arterial pathways in the body and also undergo multiple 
reflections. To better understand the wave propagation dynamics typically the wave 
ejected by the heart is treated as the forward traveling wave and the reflected 
waveforms from the peripheries is treated as the backward traveling wave [5]. The 
superposition of these two waveforms creates the waveform that is seen at every point 
along the propagation pathway. The waveform morphology itself changes along the 
propagation pathway typically increasing in systolic blood pressure (highest pressure 
achieved by) while small drops in diastolic (lower blood pressure) and mean blood 
pressure are observed [6].  
Due to its proximity to the heart, it is central aortic BP that is more informative about 
cardiac dynamics and global circulation and thus provides greater clinical value than 
those measured in the periphery. Indeed, it is increasingly accepted that central 
hemodynamic measurements can enhance CV risk prediction [7], as well as reflect 
changes in the arterial tree that is independent of brachial BP levels [8] [9]. Due to 
this importance of central aortic BP high-fidelity, point-of-care non-invasive 
measurement of central aortic hemodynamics is important for clinical CV health 
monitoring and risk assessment.  In fact, clinical research supports the central aortic 
measurements such as central aortic BP, augmentation index, reflection magnitude 
and index as well as pulse wave velocity as significant predictors of CV risk. 
1. Central Aortic BP: 
As already mentioned this parameter is very important in both health and 
disease [10],[11],[12], and accurate measurement of this parameter is a useful 
tool for the assessment of the overall CV risk [13], [14]. 
2. Augmentation Index: 
Augmentation index is defined as the ratio of augmented BP over central 
pulse pressure measured at the central aorta and is an indicator of arterial 
stiffness, wave reflection and loads imposed on the heart by the arterial tree. 
The increase of this parameter has been shown to correlate with an increase in 
CV risk [15], [16]. 
3. Reflection Magnitude and Index: 
This parameter is an indicator of relative magnitude of the backward traveling 
wave when compared to the forward traveling wave and is important because 
early wave reflection is associated with increase in load of the heart [17], [18]. 
4. Pulse Wave Velocity: 
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Pulse Wave Velocity (PWV) is the speed at which the arterial BP waveform 
propagates through the arterial pathway and is used as a surrogate measure of 
arterial stiffness [15],[19]. 
Ideally speaking the measurement and interpretation of the CV risk factors must low-
cost, easy to access, easy to use, be taken noninvasively as well as accurately and 
finally must be patient specific. To date the existing and state-of-art methods cannot 
satisfy all the constraints and each method has a significant shortcoming. 
Measurement of the central aortic BP is typically done with aortic catherization which 
is an invasive, costly, risky and uncomfortable procedure. A common noninvasive 
replacement is carotid artery applanation tonometery but while this technique is 
noninvasive it requires significant expertise and training to be done correctly and 
carotid artery BP is not always a sufficiently accurate estimate of central aortic BP 
[20]. A potential replacement may be peripheral blood pressure measurements, these 
measurements can be made noninvasively but several fundamental flaws exist in this 
approach that does not make it a suitable replacement to central aortic BP. Peripheral 
blood pressure measurements as mentioned previously differ in morphology to central 
aortic blood pressure measurements due to wave reflection phenomena and also the 
devices that seek to measure peripheral BP waveforms are typically expensive [21]. 
The Generalize Transfer Function methodology has been developed to estimate 
central aortic blood pressure from peripheral measurements but this technique is not 
patient specific and so cannot always provide an accurate or reliable estimation of 
central blood pressure [38]. Furthermore, other methods to infer  the central aortic 
blood pressure from peripheral blood pressure measurements using population 
averaged models has previously been proposed [22] and [23]. Though these methods 
do give estimates of the central aortic blood pressure they are not subject specific and 
are not tailored to each individual case and are often skewed towards the physiology 
of subjects that the population averages have been taken over and so may not 
necessarily be representative of more diverse subject pools. 
 
1.3: Thesis Objective and Outline 
The goal of this thesis is to develop an innovative low-cost and non-invasive method 
for monitoring of CV health and CVD, which can infer subject-specific central aortic 
blood pressure which can be used to evaluate CV risk factors.  The method consists of 
a low-cost and non-invasive modality for measuring arterial circulatory waveforms at 
the body’s extremity locations (such as peripheral BP waveforms, e.g., at radial and 
femoral arteries; note that peripheral measurements are easier to obtain compared 
with their central aortic counterparts) and an adaptive, subject-specific algorithm for 
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estimating central aortic CV parameters (i.e., risk factors) from the measured 
peripheral circulatory waveforms.  In the proposed framework, CV risk factors are 
derived in 3 steps.  First, two peripheral circulatory waveform signals are measured at 
the body’s diametric locations of an individual (Step 1; note that central aortic signals 
not amenable to measurement are not involved).  Second, the CV dynamics of the 
individual is characterized based on an adaptive signal processing algorithm that fits a 
CV model to the measured circulatory waveforms (Step 2; note that the resulting CV 
model can provide subject-specific CV parameters such as PWV, since it is fitted to a 
specific individual).  Third, central aortic BP waveform is estimated by de-
convolving the peripheral circulatory waveforms from the characterized CV model 
(Step 3; note that AI is also derived from the estimated central aortic BP in this step).  
There are a number of key advantages in the proposed method compared with the 
traditional methods described in the previous section: (i) the method can be 
implemented to be of low cost and non-invasive via appropriate choice of the 
measurement modality; (ii) it can eliminate the use of central aortic measurements; 
and (iii) it provides CV parameters and risk factors that are specific to individual 
subject, thereby enabling subject-specific monitoring of CV health and CVD.  In this 
regard, the proposed system has potential to meet all the aforementioned 
specifications of a medical system for CV health monitoring that is readily accessible 
to the general public to make real impact: low-cost, easy and non-invasive as well as 
accurate and reliable, and most importantly, subject-specific. 
In chapter 2 the tube-load model which is the basis of the proposed methodology is 
introduced and validated in humans. In chapter 3 the “Individualized Transfer 
Function” (ITF) methodology is introduced which uses peripheral blood pressures 
measured invasively to estimate central aortic blood pressure. The ITF methodology 
will be validated in humans using experimental data and will serve as a special case 
of the proposed methodology. In chapter 4 the “Active Noninvasive Cardiovascular 
System Identification” methodology will be introduced and discussed at length, the 
purpose of this methodology is to overcome the shortcomings of the ITF 
methodology by developing a framework to make noninvasive accurate peripheral 
blood pressure measurements and also to alleviate the issue of lack of persistent 
excitation in the signals produced by the heart. The framework is implemented with 







Chapter 2 - Validation of the Tube-Load Model in Humans 
2.1: Introduction to the Tube-Load Model and Cardiovascular Health 
Monitoring 
Substantial research effort has been put into the development of models in order to 
better understanding the cardiovascular system physiology and to develop techniques 
applicable to monitoring of arterial hemodynamic. The models developed can be 
classified into two categories: lumped parameter models and distributed parameter 
models. Lumped parameter models are structurally quite simple and are characterized 
by a small number of parameters which can be easily estimated from arterial 
waveforms available in clinical practice. Perhaps the most prevalent lumped 
parameter model is the Windkessel model [24]. Windkessel is a German word often 
loosely translated to chamber of air and in its simplest form is characterized by 2 
parameters,   and   and is depicted in Figure 2-1. As can be seen the Total Peripheral 
Resistance (TPR) of the arterial tree is modeled using a resistor (R) and the arterial 
compliance of the cardiovascular system is modeled using a capacitor (C). 
 
Figure 2-1: Simple Windkessel Model 
Although estimation and interpretation of the model parameters in lumped models are 
generally simple, these models inherently assume an infinite Pulse Wave Velocity 
(PWV) and suffer from the inability to reproduce wave reflection or propagation 
phenomena which are key in arterial waveform construction. In contrast to lumped 
parameter models, distributed parameter models are capable of describing wave 
propagation and reflection dynamics by allowing for finite PWV [25, 26]. Many 
distributed parameter models utilize simplified Navier-Stokes equations regarding 
fluid dynamics to describe wave propagation dynamics and are characterized by 
parameters that describe geometry and mechanical properties of the arteries, such 
studies include Wang et al. [27], Burattini et al. [28] and Campbell et al. [29]. Though 
these models tend to offer much more accurate reproduction of arterial 
hemodynamics, they are typically mathematically cumbersome and in practice prove 
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to be very difficult to identify reliably due to the excessively large number of 
parameters involved in their structure and this major limitation has inhibited their 
application in clinical practice. 
A middle ground model structure dubbed the tube-load model has undergone much 
investigation due to its ability to describe wave propagation and reflection dynamics 
while simultaneously being mathematically tractable and characterisable by a small 
number of parameters. As this class of model has gained popularity it has been used 
in the estimate of important clinical hemodynamic measures such as cardiac output 
(CO) in studies such as Welkowitz et al. [30], aortic blood pressure (BP) and flow 
(BF) waveform in studies such as Karamanoglu et al. [22]. Most existing efforts have 
aimed to reconstruct or infer information about the central aortic blood pressure due 
to the importance of this measure in clinical practice. 
Due to the potential applicability of these models in clinical settings, substantial effort 
has been put into the validation of the tube-load models, though the vast majority of 
research efforts have been geared towards the validation of these models in animals. 
Table 2-1 depicts research efforts geared towards the validation of the tube-load 
model in living beings. 
Table 2-1 Studies of the Validation of Tube-Load Model 
Year Lead Author Species 
1989 Burattini [28] Canine 
1990 Campbell [29] Canine 
1993 Berger [31] Canine 
1995 Shroff [32] Canine 
1997 Fogliardi [33] Canine 
2000 Segers [34] Canine 
2009 Hahn [25] Swine 
2010 Xu [35] Canine 
There have only been a hand full of instances of the application of the tube-load in 
humans and even fewer studies attempting to quantitatively validate these models in 
humans. The primary reason why such few studies exist in humans is due to fact that 
arterial blood pressure measurements are difficult to accomplish at multiple points 
simultaneously, especially if one of these blood pressures is estimated at or close to 
the left ventricle of the heart. It is important to note that even with the existence of the 
difficulty of such measurements; establishing the validity of tube-load models in 
humans will provide a strong basis to extend the applicability of ongoing advances in 
novel cardiovascular monitoring method ([25], [32], [36] and so on) in humans. 
7 
 
In this chapter the contribution of this thesis related to the validation of the tube-load 
model in humans is discussed. In order to achieve this end the tube-load model is 
discussed in detail and a mathematical treatment of the identifiability and validation 
of tube-load model in humans is provided using clinical data measured from humans 
undergoing cardiopulmonary bypass. It is noted that the material in this chapter was 
presented by the author in [62]. 
2.2: Tube-Load Model Mathematical Formulation 
Due to the importance of the tube-load model as a basis to many novel cardiovascular 
monitoring methods and it’s potential as a highly prevalent model of the human 
hemodynamics, a through mathematical treatment as well analysis of structural 
identifiability are a necessary prerequisite to validation of the model in humans using 
experimental data. The tube-load model is a concept taken from transmission line 
theory and consists of a conduit (tube) ending with a load and being driven by some 
source, and in this study 2 tube-load models are analyzed, the 1 tube-load model and 
the 2 tube load model. The 1 tube-load model considered in this thesis is comprised of 







Figure 2-2 Tube-Load Model - Lossless Conduit Terminating with a Windkessel 
Load 
Figure 2-2 depicts the considered 1 tube-load model, where    denotes the conduit 
characteristic impedance,    represents the distal arterial compliance,    denotes the 
peripheral resistance and    denotes the load impedance. The load impedance can be 
calculated as below: 
 
      
  
       
 
(1) 
Where   denotes the Laplace frequency domain variable. It is important to note that at 
high frequencies the load impedance approaches the characteristic impedance, this 
means that high frequency waves do not undergo any reflection at the load site and 
are absorbed by the load, this is a critical characteristic of physiological 
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cardiovascular systems [29]. The transfer function relating central aortic blood 
pressure (  ) to peripheral blood pressure (  ) is given by: 
 
  ( )   ( )  ( )  
   ( )
         ( )
  ( ) 
(2) 
Where   denotes the Pulse Transit Time (PTT) which is the time required for the 
wave to propagate from one end of the tube to the other end and  ( ) denotes the 
reflection coefficient defined by Equation (3): 
  ( )  
  ( )    
  ( )    
 (3) 
Replacing   ( ) into Equation (3): 
 
 ( )  
  
         (      )
 
  
    
 
(4) 
Where    
      
       
 and    
  
       
, now replacing the    and    expressions into 
Equation (2): 
 
  ( )   ( )  ( )  
       
(    )          
  ( ) 
(5) 
It is shown that the transfer function relating central and peripheral blood pressures is 
characterized by 3 parameters, the PTT and 2 polynomial coefficients. 
The 2 tube-load model is comprised of two tubes with a resistor between the tubes 
(Figure 2-3). The resistor between the 2 tubes represents the blood flow loses due to 
bifurcations (for example the bifurcation of the brachial at the elbow into the 
radial/ulnar or the bifurcation of the descending aorta to the abdominal and femoral 













Figure 2-3 2 Tube-Load Model 




  ( )     ( )  ( )  
    ( )
            ( )
  ( ) 
(6) 
where    is the PTT for the first tube and    is the reflection coefficient at the output 
of the first tube due to the discrepancy between the characteristic impedance of the 
first tube     and the load impedance     that is due to the input impedance of the 
second tube and the resistance  : 
 
  ( )  
   ( )     
   ( )     
 
      ( )     
      ( )     
 
(7) 
where // denotes a parallel connection and     denotes the input impedance of the 
second tube and is given by [26]: 
 
   ( )     
        
    
            
 
(8) 
here     is the characteristic impedance of the second tube and    is the pulse transit 
time associated with the second tube.    is the reflection coefficient at the interface of 
the second tube and the load given by: 
 
  ( )  
  ( )     
  ( )     
 
  
          (       )
 
  
    
 
(9) 
where    
       
        
 and    
  
        
. Next by combining             with 
Equations (8) and (9) yields: 
 
   ( )  
    [(    ) 
       
    ]
(     )(    )       (     )     
 
(10) 
Imposing negligible wave reflection occurring to the outlet of first tube at high 
frequencies yields the following relationship between the characteristic (   ) and load 
(   ) impedances associated with the first tube: 
 
       
   
   ( )  
    
     
 
(11) 
Substituting (10) and (11) into (7),    is obtained as follows: 
 
  ( )  
    
    
(     )(    )               
 
(12) 
Subsequently, substituting (12) into (6) yields the following    ( ): 
    ( )
 (   
  )
(    ) 
       
    
(     )(    ) 
(     )        
(     )       





On the other hand, the relationship between    and the peripheral BP    is given by 
(5), with   and    replaced by    and    , respectively: 
 
  ( )     ( )  ( )  
       
(    )            
  ( ) 
(14) 
Using (13) and (14), the relationship between    and    is given by: 
   ( )     ( )   ( )  ( )
 
(     )(    ) 
       
    
(     )(    ) 
(     )        
(     )       
(     ) 
       
(    )            
  ( ) 
(15
) 
In summary, the 2-TL model above is characterized by six parameters in total: PTT 
   and   , bifurcation resistance  , characteristic impedance     (or    
   
     
   ), 
and polynomial coefficients    and   . 
 
2.3: Blood Pressure Wave Propagation along the Tube-Load Model 
All physical systems suffer from energy dissipation, also referred to as loss and the 
wave propagation dynamics in the human arterial system are no exception to this rule. 
The losses arise from head-loss associated with the friction of the motion of the fluid, 
the changes in arterial cross section as well as with bifurcations. In this study we have 
neglected losses since it has been shown that in major arterial pathways compliance is 
relatively high and losses are negligible, such pathways are the descending aorta (the 
prominent pathway from the central to the femoral line we have considered) and the 
subclavian (which is a prominent portion of the brachial line considered). It is noted 
that to account for the losses creating a difference in biases between the central and 
peripheral blood pressures these differences in mean were eliminated which overall 
does not alter the methodology since the tube load model has a gain of 1 at zero 
frequency. 
Transmission line theory allows for wave specific phenomena such as the presence of 
static waves and wave amplification. Static waves are waves that are produced when 
the wavelength of the input signal takes on a specific fraction of the length of the 
tube, such fractions are ¼, ½, ¾ and 1. In these cases the overall wave that is seen as 
an observer is that of a static wave (the sum of the forward and backward traveling 
wave) with nodes and troughs. The heart beats at a frequency of 1 Hz and produces 
waves that propagate at speeds of between 1 and 3 meters per second. The 
wavelength of these waveforms when compared to the length of the tubes (anywhere 
between 0.8 to 1.5 meters) would indicate the highly unlikely event that static waves 
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would appear and would also rule out the possibility of resonance occurring which 
are not observed in the human cardiovascular system. 
 
2.4: Data Collection Protocol 
Following the approval from the University of Alberta Health Research Ethics Board 
(ID: Pro00021889) and informed consent from the patients, BP waveform data 
required to validate the tube-load models (i.e. invasive central aortic, radial and 
femoral BP) were collected from patients undergoing CABG with CPB. Our inclusion 
criteria were 1) written informed consent, 2) age 18 through 80 years, inclusive, and 
3) scheduled for CABG with CPB, whereas our exclusion criteria were 1) scheduled 
for heart surgery other than CABG that can incur distortion of central aortic BP 
waveform (e.g. aortic valve repair etc.), 2) female of childbearing potential, 3) 
emergency surgery, and 4) body mass index (BMI) greater than 35. To acquire BP 
waveform data and assess the validity of the tube-load models in diverse physiologic 
conditions, the data were collected both before and after the CPB procedure. The 
rationale behind collecting BP data both before and after the CPB procedure was that 
prolonged anesthesia induces significant hemodynamic changes [37], and ventricular 
performance immediately after cardiac surgery may also be impaired. Consequently, 
we expected to secure data for validating the tube-load models in two distinct 
hemodynamic conditions per subject without introducing any exogenous 
interventions, e.g. administration of vasopressor drugs. The BP data were collected 
for the duration of 2 minutes, both before and after the CPB procedure [59]. 
Our experimental setup is visualized in Figure 2-4. Initially a catheter was inserted 
into the radial artery and the anesthesia was applied to the patient. Next a second 
catheter was inserted into the femoral artery and just before and following the CPB, a 
cannula was inserted into the aorta by a surgeon, and BP waveform recordings were 
obtained from all three cannula at a sampling rate of 1 kHz. Data from the BP 
transducers (TruWave PX, Edwards Life Sciences, CA, USA) were transmitted to a 
patient monitor in the operating room (IntelliVue MP90, Philips Healthcare, The 
Netherlands). BP waveform data were conveyed to data acquisition equipment 
(MP150, Biopac Systems Inc., CA, USA) using a custom-built interface cable and a 
blood pressure module (M1006B, Philips Healthcare, The Netherlands). The 
equipment was properly calibrated before the beginning of each surgical case to 












TruWave PX IntelliVue MP90
 
Figure 2-4 Experimental Setup - Data Collection 
Hemodynamic measures of the subjects enrolled in the study are listed in Table 2-2, 
which indicates that the subjects were in diverse physiologic states. In particular, PTT 
values (which are known to largely affect the tube-load model [25, 38]) exhibited 
large inter-individual differences; maximum differences of 109 ms and 87 ms in the 
aortic-femoral PTT were observed before and after CPB, respectively. Moreover, the 
physiologic states of the subjects before and after CPB were greatly varied in values 
(see Table 2-2), though statistical significance was not established due to the small 
number of data. The diversity in hemodynamic conditions among different subjects 
made it possible to rigorously assess the validity of the tube-load models under a wide 
range of physiologic states. Figure 2-5 shows the radial blood pressure waveform for 
the first 5 subjects, the diversity in the data can clearly be seen be the dramatic 
differences between waveforms. 
Table 2-2 Hemodynamic Measures of the Subjects used in the Validation of the 
Tube-Load Model 
Subject ID 





































































































Mean+/-SD 63.2+/-10.0 74.0+/-14.5 99.6+/-22.5 43.5+/-14.4 84.3+/-20.0 78.0+/-9.2 67.5+/-14.7 93.6+/- 42.1+/-7.4 79.6+/-36.7 
13 
 
74.2+/-18.5 17.4 70.0+/-26.2 
 
Figure 2-5 Radial Blood Pressure of First 5 Subjects 
2.5: Tube-Load Model System Identification Procedure 
To perform system identification, for each patient 35 second long stable central, 
radial and femoral blood pressures were extracted from the recordings once for pre-
CPB and once for post-CPB from the original 2 minutes of data recorded and were 
then down-sampled to 100 Hz. Next the transfer functions were converted to their 
discrete-time domain equivalents, and the forward difference approximation   
  (   ) was used to estimate the continuous time models by discrete time ones.    
denotes the sampling frequency (here 100 Hz). Using the forward difference 
approximation Equation (5) can be re-written as: 
 
  ( )  
    
  (     )   
     (        )            
 
(16) 
where   [   ] is the discrete-time domain PTT and the brackets ([ ]) denote 
rounding to the nearest integer digit. The estimate of the central aortic BP can be 
calculated from the peripheral BP using the discrete transfer function by using: 
  ̂ ( )   
  {  
  ( )  ( )} (17) 
Where  { } is the Z-transform. The difference equation (17) can be written as: 
  ̂ (   )  [  
(     )
  
]  ̂ ( )   (  ( )) (18) 
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where  ( ) is given by: 
  (  ( ))    (     )  (  
      )  (   )
   
      (   ) 
(19) 
Therefore the 1 tube load model is identified by minimizing: 
   ‖    ̂ ‖  √∑[  ( )   ̂ ( )]
 
 
   
 (20) 
Essentially the optimization problem (20) is defined as the 2-norm of the discrepancy 
between measured and estimated central aortic blood pressure and   is the number of 
data points considered. The optimization problem (20) is constrained by the fact that 
all physiological parameters must be bigger than or equal to zero for physiological 
relevance and that    but be bigger than   , this is a trivial conclusion given the 
definitions of these parameters, i.e. that: 
 
   
      
       
    
  
       
 
(21) 
Given these constraints model identification reduces to the constrained optimization 
problem: 
   
     
     
 (  )     
     
‖    ̂ ‖ (22) 
where    {       } and    {  |           }. 
The 2 tube load model is also identified utilizing the same procedure outlined above 
for the 1 tube load model, the constrained optimization is defined as: 
   
     
     
 (  )     
     
‖    ̂ ‖ (23) 
 
where    {                } and 
   {  |                          }. 
 
2.6: Tube-Load Model Validity in Humans 
The validity of 1 tube-load and 2 tube-load models were assessed in terms of the 




For each subject both before and after the CPB, the validity of tube-load models for 
central aortic-radial and central aortic-femoral arterial paths were evaluated as 
follows. For each arterial path, the optimal estimated central aortic BP was obtained 
by applying peripheral (i.e. radial or femoral) BP waveform to 1 tube-load and 2 tube-
load models of the corresponding arterial path identified from (21) and (22), 
respectively. The accuracy of estimated central aortic BP was quantified in terms of 
the root-mean-squared error (RMSE), the coefficient of determination (r2 value) and 
the limits of agreement (via the Bland-Altman statistics) between measured versus 
estimated central aortic BP waveforms, systolic and pulse pressure errors, and the 
errors associated with measured versus identified PTT values.  
In addition to central aortic BP, the frequency responses estimated by the 1 tube-load 
and 2 tube-load models were compared with the actual, underlying frequency 
responses as follows. For both 1 tube-load and 2 tube-load models, the optimal 
estimated frequency responses were calculated by substituting      to (5) and (15) 
with optimal model parameters identified from (21) and (22), respectively: 
 
  (  )    ( )|    
  (  )    ( )|        (  )   (  )
 (24) 
where   ( )     ( )   ( ). On the other hand, the actual frequency responses were 
obtained as ETFE, by applying the measured central aortic and peripheral BP data to 
the “TFE” routine in MATLAB Signal Processing Toolbox. 
The effectiveness of the 1 tube-load and 2 tube-load models were compared in terms 
of the metrics evaluated for the central aortic BP. The difference was regarded as 
statistically significant if the p value calculated by the Student’s t-test was evaluated 
less than 0.05. 
The identified model parameters associated with 1 tube-load and 2 tube-load models 
are summarized in Table 2-3 for both aortic-to-radial and aortic-to-femoral arterial 
paths, and the corresponding box plots are shown in Figure 2-6. Overall, the 
identified model parameters exhibited a large degree of inter-individual variability, as 
expected from the diversity in hemodynamic conditions observed in the data (see 
Table 2-2). 
 
Table 2-3 Identified Model Parameters for the 1 Tube-Load and 2 Tube-Load Models 
(a) 1-TL model (mean+/-SD) 
Parameter 
  [ms]       
Upper-Limb Lower-Limb Upper-Limb Lower-Limb Upper-Limb Lower-Limb 
Mean+/-SD 86.9 17.8 64.4 18.6 94.6 34.3 82.5 37.1 16.6 19.1 40.6 24.7 
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Min/Max 50/120 50/110 24.0/156.3 10.8/134.6 0.01/56.8 3.3/83.0 
 
 (b) 2-TL model (mean+/-SD) 
Parameter 
   [ms]      
Upper-Limb Lower-Limb Upper-Limb Lower-Limb Upper-Limb Lower-Limb 
Mean+/-SD 41.9 24.6 53.1 27.3 15.4 10.5 48.6 32.4 2.1 3.9 1.2 2.4 
Min/Max 10/80 0/110 1.8/30.6 5.7/97.7 0.01/14.0 0.01/9.6 
Parameter 
   [ms]        






Mean+/-SD 40.6 23.2 23.8 9.6 11.5 8.6 45.4 31.3 10.7 19.9 178.5 429.9 






Both 1 tube-load and 2 tube-load models resulted in high-fidelity representations of 
central aortic-peripheral arterial BP relationships. First of all, the estimated central 
aortic BP waveforms, both before and after CPB, were very close in morphology to 
their true counterparts (see  Figure 2-7); on average, RMSE between true versus 
estimated BP waveforms were only 4.81% and 3.70% of the underlying MAP for 1 
tube-load and 2 tube-load models, respectively, and the r2 values between them were 
also very high (see Table 2-4 and  Figure 2-8). The Bland-Altman analysis indicated 
that the models boast negligible bias and tight limits of agreement (see Table 2-4 and 
Figure 2-8). In addition, PTT values identified for both 1 tube-load ( ) and 2 tube-
load (     ) models were highly consistent with those measured in terms of 
diastolic foot-to-foot time interval [39] (see Table 2-4 and  Figure 2-9). Noting that 
the accuracy of PTT has predominant impact on the fidelity of tube-load models [25, 
39], small PTT errors as listed in Table III suggest that both 1 tube-load and 2 tube-
load models were properly identified for all subjects enrolled in this study. Indeed, a 
representative true versus model-derived frequency responses shown in  Figure 2-7 
suggest that the identified tube-load models can reproduce the underlying frequency 
response with satisfactory accuracy, especially the location and amplitude of the first 
peak response that is critical for reliability of tube-load models [25]. It is noted that 
the frequency content of the signals produced by the heart are limited to the first 3-4 
harmonics and beyond these frequencies there is essentially little to no information 
which is also seen in Figure 2-7 where there is a sharp reduction in the magnitude 
plots at frequencies above 4 Hz (the heart rate of this subject is approximately 1 Hz). 
In essence, the results obtained in this study strongly support the validity of 1 tube-




Figure 2-6 Box plot of tube-load model parameters 
 
(a) 1-TL model. 
 
(b) 2-TL model. 
Figure 2-7 Measured versus estimated central aortic BP waveforms and upper-/lower-
limb frequency responses 
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Table 2-4 compares the metrics pertaining to central aortic BP between 1 tube-load 
and 2 tube-load models. First, 2 tube-load model outperformed its 1 tube-load 
counterpart with statistical significance (      ) in reproducing high-fidelity 
central aortic BP waveform, in that 2 tube-load model was superior to 1 tube-load 
model in terms of all the metrics indicative of morphological accuracy of the BP 
waveform including RMSE, r2 value and limits of agreement between measured 
versus estimated central aortic BP waveforms. In particular, RMSE was consistently 
smaller for 2 tube-load model than 1 tube-load model, which was expected from the 
fact that 1 tube-load model is a special case of 2 tube-load model. In fact, it is obvious 
from Figure 2-3 that 2 tube-load model reduces to 1 tube-load model by removing a 
tube segment (either tube #1 or tube #2) and setting    . Indeed, it can be easily 
verified that 2 tube-load model (15) reduces to 1-TL model (5) by setting      and 
   , or by setting      and    . Since the cost function associated with the 
model identification (21) and (22) is to minimize the RMSE discrepancy between 
measured versus estimated central aortic BP waveforms, 2 tube-load model (which is 
equipped with more tunable model parameters than its 1 tube-load counterpart) is 
expected to yield smaller RMSE than 1 tube-load model. Despite statistical 
difference, however, the amount of improvement achieved by 2 tube-load model over 
1 tube-load model does not appear to be large enough to make 2 tube-load model 
more preferable to 1 tube-load in terms of model’s practical utility (e.g. r2 value 
difference was only 4% on average). On the other hand, metrics related to distinct 
features in the BP waveform (i.e. SP, PP and PTT) were essentially comparable and 
were not statistically different. Note that 1 tube-load model appears to be better than 2 
tube-load model in terms of PP and PTT errors (bias of the errors was smaller for 1 
tube-load model; see Table 2-4), but the amount of difference was negligible when 
compared with the underlying values (see Table 2-2). 














1-TL 3.24 1.2       5.17 0.19 6.85 -0.16 16.4 0.9251 0.0762 0.04      
2-TL 2.52 0.9       4.27 0.97 5.43 -2.66 15.0 0.9602 0.0281 0.03 5.30 




Figure 2-8 Correlation and limits of agreement between measured versus estimated 
central aortic BP waveforms 
 
Figure 2-9 Correlation between measured versus estimated PTT values 
Regardless of superior efficacy of the 2 tube-load model to reproducing the central 
aortic-peripheral BP relationships in comparison with 1 tube-load model, 1 tube-load 
model can still be regarded as a viable model based on the following observations. 
First, the improvement achieved by 2 tube-load model over 1 tube-load model was 
modest but not large (see Table 2-4). Second, 2 tube-load model sometimes tended to 
reduce to 1 tube-load model (in that the values of    or    assumed the lower bound 
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of 0 ms and   assumed very large value as indicated by the minimum values of    
and    as well as the maximum value of   in Table 2-3), although the conditions on 
the data under which this tendency occurred (i.e. 1 tube-load model rather than 2 
tube-load model sufficed to reproduce central aortic-peripheral BP relationships in the 
data) is still an open question. Third, the values of PTT obtained for 2 tube-load 
model were not always physically meaningful. In fact, PTT values for 2 tube-load 
model were expected to satisfy       since the first segment in 2 tube-load model is 
intended to represent the major compliant arteries (i.e. brachial and descending 
aortic/abdominal) in which PWV is relatively slow, considering that   is intended to 
represent losses due to brachial-radial and abdominal-femoral bifurcation and 
splanchnic organs. However, this was not always the case and often 2 tube-load 
models with       were obtained. In essence, the 2 tube-load model was superior to 
1 tube-load model in fidelity, but care needs to be taken when interpreting its 
physiological implications. 
2.7: Limitations 
In terms of practical limitations, the tube-load model outlined and verified in this 
chapter requires blood pressure measurements recorded at two diametrically opposed 
limbs and these measurements need to be done invasively, which comes at a cost and 
risk to the patient and is difficult to perform. In the later chapters steps will be taken 
to develop a methodology that allows for the noninvasive measurement of peripheral 
blood pressures. 
In regards to the quality of the data itself it is noted that the frequency content of the 
signal is limited to the heart rate and the first 3 to 4 harmonics of the heart rate (over 
90% of the signal energy). This leaves very little to no frequency content outside of 
these peaks and particularly at higher frequencies but as can be seen from the results 
the tube-load model has been successful in in characterizing the central to peripheral 
blood pressures accurately and reliably, indicating a good fit of the parameters. The 
inherent nature of the physiological system producing and propagating the blood 
pressure waveforms is such that the signal is not frequency rich but should a richer 
signal be utilized in fitting the model it is anticipated that better parameter estimates 
can be achieved. 
2.8: Summary 
In this chapter we proposed and validated two distinct tube-load models to describe 
the relationship between central aortic and peripheral BP waveforms in humans. The 
experimental results shown indicate that both models could fit the central aortic-radial 
and central aortic-femoral BP waveform pairs effectively, although the 2 tube-load 
model was consistently superior to the 1 tube-load model with statistical significance 
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as far as the accuracy was concerned. Specifically, the models could estimate PTT 
accurately, and the model-derived frequency response was also close to the empirical 
transfer function estimate (ETFE) obtained directly from the central aortic and 
peripheral BP waveform data. We conclude that the tube-load models considered are 
valid representations to reproduce central aortic-radial/femoral BP waveform 
relationships in humans. Future work will include development and in-human 



















Chapter 3 - Validation of the Individualized Transfer 
Function Methodology (ITF) in Humans 
3.1: Introduction to ITF and its application to Cardiovascular Health 
Monitoring 
Substantial research effort has been put into developing methods of cardiovascular 
health monitoring techniques that utilize the central aortic blood pressure (CABP) due 
to its greater physiological and clinical relevance when compared to peripheral BP. 
Systolic blood pressure (SBP) and pulse pressure (PP) that are measured at the central 
aorta are an accurate reflection of cardiac afterload and myocardial perfusion. Also to 
note is that blood pressure (BP) applied to the central (compliant) arteries, as opposed 
to the peripheral arteries, is a major determinant of the degenerative changes that 
occur in hypertension and aging [23]. It has been shown that CABP, and not 
peripheral BP, is an independent predictor of mortality and/or cardiovascular events 
in geriatric patients [11], end-stage renal disease patients [10] and coronary artery 
disease patients [12]. Further CABP has been shown to have a stronger correlation to 
age [40] and better establish the seriousness of coronary artery disease [41] when 
compared to peripheral BP. Despite the usefulness of CABP, in practice it is difficult 
to measure and often involves expensive and invasive measurements that induce 
significant discomfort to the patient. In contrast peripheral BP can be measured both 
easily and safely and so has become routinely measured in practice. 
Many studies have attempted to relate peripheral arterial BP (ABP) measured at distal 
extremities to CABP. The most well-known approach is the Generalized Transfer 
function whose accuracy and effectiveness has not been fully accepted [34]. Several 
novel approaches have recently been proposed for subject-specific estimation of 
CABP [25]and [42], specifically Hahn et al. [25] showed that CABP can be estimated 
via a cardiovascular system model derived by applying system identification to two 
diametrically opposed circulatory measurements (e.g. radial and femoral BPs). This 
individualized transfer function (ITF) approach has been validated on animal subjects 
to be able to estimate CABP and aortic-to-peripheral pulse transit time (PTT: 
equivalent to arterial distance divided by pulse wave velocity) [25]. 
The objective of this chapter is to demonstrate the in-human validity of the ITF 
approach. In order to achieve this end experimentally collected data from patients 
undergoing cardio-pulmonary bypass is utilized to establish the validity of ITF by 
showing that (i) the approach can reliably derive the cardiovascular model and (ii) it 
can accurately and robustly estimate the CABP. To the best of our knowledge this is 
the first study to experimentally evaluate the efficacy of the subject-specific 
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estimation of CABP method in humans. In section 2 the tube-load model of the 
human cardiovascular tree will be introduced and described mathematically using the 
framework introduced in chapter 2, next in section 3 estimation of CABP via system 
identification is broken down and in sections 4 and 5 results are presented and 
discussed 
3.2: Tube-Load Model of the Cardiovascular System 
The ITF methodology is based on the idea that the cardiovascular (CV) system can be 
modeled using two tube-load models to represent the wave propagation pathways. In 
this model the arterial tree is approximated by the upper and lower body tube 
segments. Figure 3-1 illustrates the asymmetric two tube-load model of the 
cardiovascular system utilized in this thesis. 
 
Figure 3-1 Asymmetric two tube-load model of the cardiovascular system 
The tube-load models utilized in this study are assumed to be lossless and each tube 
has a characteristic impedance denoted by    and PTT denoted by  . Each tube is also 
terminated in a Windkessel load that is made up of the lumped compliance in the 
distal arteries (  ), peripheral resistance exerted by the arterioles (  ) and 
characteristic impedance (  ) to reproduce zero wave reflection at infinite frequency 
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 (25) 
where  ( ) is BP,    
      
       
,    
  
       
, and the subscripts A, R and F are 
central aortic, upper-body (e.g., radial) and lower-body (e.g., femoral) locations, 
respectively. The model (25) is characterized by six parameters: 
  {                     }. 
The key reasons why two tubes have been deemed sufficient in the characterization of 
the human arterial tree is that: 
1. System identification applied to more complicated models will involve the 
estimation of a larger set of parameters, which would in turn mean reduced 
confidence intervals of parameters (an increase in variance) and would 
complicate the search space unnecessarily, which would also mean that 
finding a minimum numerically in the search state would become increasingly 
difficult with the increase in level of complexity of the model. 
2. In previous studies in animals it has been demonstrated that two tubes was 
sufficient in characterizing the subject’s arterial tree dynamics and so as a 
preliminary step in validation of the ITF methodology the same scheme is 
applied to humans and if it proves ineffective then the number of tubes can be 
increased. In this chapter it will be shown that two tube models are sufficient 
for accurate and robust characterization of subject specific arterial tree 
models. 
3.3: Estimation of CABP via System Identification 
The estimation of the CABP through the ITF methodology involves a 2 step 
procedure: 1) identifying the cardiovascular hemodynamics which essentially boils 
down to the identification of the asymmetric tube-load model of the arterial tree and 
2) Passing the peripheral blood pressures through the identified dynamics to estimate 
the CABP in a process called deconvolution. In section 3.3.1 the identification 
formulation, criteria for identifiability and identification procedure are outlined, next 
in section 3.3.2. the input deconvolution procedure and the estimation of the CABP is 




3.3.1: Formulation and System Identification 
The ITF methodology seeks to estimate the CABP by first identifying the arterial 
wave propagation pathways represented by the two tube-load models connected in 
parallel, next utilizing the identified dynamics and the peripheral blood pressure 
measurements the approach reconstructs CABP through a process called 
deconvolution which is essentially passing the peripheral measurements through the 
inverse of the identified dynamics. The key to being able to identify the arterial 
pathway dynamics without the original input (the CABP) is that the peripheral BPs 
are produced by a common source, the CABP so ITF seeks to exploit this 
commonality and it can be concluded that: 
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Equation (26) indicates that the transfer functions characterizing the upper and lower 
segments of the arterial tree (  ( ) and   ( ) respectively) can be determined by 
solving the following constrained optimization problem: 
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(27) 
where the expressions for the tube-load model introduced in (2) have been used to 
characterize the transfer functions in terms of the parameters pertaining to the tube-
load models. Equation (27) can naturally be formulated into the following cost 
function for system identification via optimization: 
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which can be minimized over the set of unknowns given by: 
   {                     } (29) 
which yields: 
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 }        
   
 ( ) (30) 
where    is the optimal parallel tube-load model parameters,   is the parameter. 
Three physiological constraints can be applied to the optimization problem defined in 
(30). These constraints can be incorporated into the system identification procedure as 
follows: 
1. Due to the fact that the valley of the BP waveform is the most reliable and 
robust segment of the waveform in regards to distortions caused by wave 
reflection, it is assumed that the difference in PTT in the upper a lower BP 
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measurements is equal to the temporal difference between the two valleys of 
the peripheral blood pressures and can be described by the relationship: 
 
          (31) 
where    is the “differential” time delay.  
 
2. Due to the physiological implications of the parameters characterizing the 
tube-load models, they must take on positive values and so the following 
constraints must hold: 
     ,      ,      ,     ,      ,       (32) 
 
3. Careful inspection of the definitions made for    and    dictates that: 
 
      
 
    
    
 
    
     
(33) 
which yields the following constraints on the relative magnitudes of     
versus     and     versus    : 
                            (34) 
 
In order to be able to uniquely identify the parallel tube-load models based on the 
constrained optimization in (28) two conditions must be satisfied: 
 
1. It is noted that (26) can be rearranged to yield a standard input-output system 
identification setup as in: 
 
  ( )  
  ( )
  ( )
  ( )
 
         
(     )             
(     ) 
        
    
         
  ( ) 
(35) 
Therefore solving the optimization problem set forward in (30) yields the ratio 
of   ( ) to   ( ). For the parallel tube-load model to be completely 
characterized, pole-zero cancellation must be avoided in this ratio. This 
condition simply means there must be no common factors between the 
numerator and denominator of the transfer functions characterizing the arterial 
pathways, in mathematical terms: 
          |             
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Checking the condition set forward by (36) is only possible post system 
identification phase but it is anticipated that this condition can readily be met 
in the specific case of the CV system in that the load characteristics and PTTs 
pertaining to the tube-loads are highly distinct since the circulations in the 
upper and lower body are significantly different. 
2. It has been shown in [25] that to decompose the ratio of   ( ) and   ( ) into 
its individual constituents uniquely a sufficient condition dubbed the “blind 
identifiability condition” has to be satisfied. Utilizing this condition on the 
ratio of   ( ) and   ( ) yields the following condition applied to PTT    and 
  : 
               (37) 
 
where    is the sampling frequency. As suggested by [25], (37) can be 
satisfied by appropriate selection of peripheral BP measurement locations and 
sampling frequency and acts more as a guideline then restriction imposed on 
the identification procedure. 
3.3.2: Input Deconvolution 
In section 3.3.1 the procedure to identify the asymmetric tube-load models was 
outlined and criteria were set forward to ensure uniqueness and reliability of the 
identified transfer functions relating peripheral and central BPs. In order to 
reconstruct the CABP an inverse filtering approach was utilized as the deconvolution 
technique due to the fact that the tube-load models are minimum phase [25]. Each 
peripheral BP measurement is inverse filtered through its corresponding transfer 
function and the commonality of the CABP is exploited by noting that: 
  ̂ ( )      
  ( )  ( )      
  ( )  ( ) (38) 
where  ̂ ( ) is the estimated CABP, and    and    are weights satisfying       
 . 
3.3.3: Asymptotic Variance Analysis: Reliability of Tube-Load Model 
In section 3.3.1 and 3.3.2 the procedure for estimating CABP from peripheral BPs 
utilizing the ITF approach was outlined. The accuracy and reliability of the approach 
can be assessed by comparing estimated and measured CABPs but it is also noted that 
this criteria is not the only important criteria that must be checked. Through variance 
analysis the reliability of the estimates of the model parameters can be assessed to 
give an indication of the fidelity of these estimates. Due to the fact that prior 
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knowledge of the true model parameters is never available calculation of exact 
variance is not generally possible, but expected variance can be estimated as the 
“asymptotic” variance using model structure and measurements [43], which 
converges to: 
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where    and  
  are the vectors of true versus estimated model parameters,   is the 
length of the data used for system identification,   ( )  
 
 
∑   (   )     is the 
variance of the measurement error  , and   ( ) is the inverse of the sensitivity 
covariance matrix. The empirical error   can be defined as follows, where   is the 
vector of tube-load model parameters: 
  (   )     {  
  (   )  ( )    
  (   )  ( )} (40) 
where     is the inverse Laplace transform. As noted previously the variance in (40) 
is not computable since it is evaluated at    (which is unknown in most real-world 
problems). However, the following empirical approximation using the estimate    
suffices in many real-world problems: 
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Using the parametric asymptotic variance    (     ) thus obtained, the variance 
associated with the estimation of tube-load models   ( ) and   ( ), 
   (  ( 
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     )),      , can be obtained as follows [43]: 
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3.4.1: Experimental protocol 
The experimental protocol is the same as outlined in chapter 2 but will be reiterated 
for the purpose of completeness. After receiving approval from the University of 
Alberta Health Research Ethics Board (ID Pro00021889), BP waveform data required 
to assess the ITF approach (invasive CABP plus radial and femoral BP) were 
collected simultaneously from thirteen patients undergoing cardiac surgery with 
cardiopulmonary bypass (CPB). Noting that prolonged anesthesia induces significant 
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hemodynamic changes [37], and also that ventricular performance immediately after 
cardiac surgery may also be impaired, data were collected both before and after CPB 
to assess the validity of the ITF approach under diverse physiologic conditions. The 
data were collected for the duration of 2 min at a sampling rate of 1 kHz. The data 
was then downsampled to 100 Hz to lower the computational costs of the 
optimization.  
 
Figure 3-2 ITF approach: measured versus estimated CABP (Subject #3, post-CPB). 
Solid: measured CABP. Dashed: estimated CABP. 
3.4.2: Validity of the ITF Approach 
Data taken from the subjects was applied to the ITF approach as outlined in the 
previous sections and the calculated errors in relation to CABP and its estimate are 
summarized in Table II. This table also includes the direct peripheral BP and the GTF 
approach as estimates of the CABP to provide a measure of accuracy. A 
representative snapshot of measured versus estimated CABP is illustrated in Figure 
3-2 comparing the estimations made from each approach. The ITF approach could 
reliably and accurately reproduce CABP and when compared to radial and femoral 
BP, it improved RMSE in CABP waveform by 34% and 42% (p<0.05), SP errors by 
67% and 76% (p<0.05), and PP errors by 78% and 85% (p<0.05), respectively. 
Noting that radial BP is closer in morphology to the CABP, it is expected that the ITF 
methodology will have greater improvement over femoral BP estimates then Radial 
BP estimates as can be seen from the table. The ITF approach also showed benefit 
over the GTF approach, with 44% and 75% improvements in SP and PP errors 
(p<0.05) in addition to a moderate improvement in RMSE (11% percentagewise; 
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though statistically significant difference could not be established with the sample 
size). 
In order to ensure the satisfaction of the identifiability conditions (36) and (37) were 
evaluated numerically using the optimal solutions found from the ITF approach, and 
held for all patients, both pre- and post-CPB. The asymptotic variance analysis 
indicated that the parallel tube-load model was determined reliably as far as CABP is 
concerned. It was also noted that not all the tube-load model parameters can be 
identified reliably. Specifically the analysis showed that     was the most difficult to 
identify by the ITF approach prompted by the fact that it involves the largest 
asymptotic variance. 
Table 3-1 Physiologic envelope of the cardiac surgery patients. PTT is shown for both 
central aortic-radial and central aortic-femoral paths. 
Subject ID 
(Age/Sex) 





















1 (61/M) 48.0 66.6 86.2 33.6 118.4/146.8 82.2 97.4 131.8 54.1 77.5/079.3 
2 (51/M) 68.6 69.6 92.5 38.1 091.4/102.8 80.6 60.2 79.5 32.4 93.9/127.7 
3 (63/M) 72.0 83.5 120.9 61.4 087.1/043.4 72.0 57.1 83.8 41.1 97.4/040.5 
4 (52/F) 78.8 68.8 85.2 29.2 100.5/082.9 85.7 72.0 95.7 37.4 86.7/071.7 
5 (79/F) 63.4 88.3 110.5 43.3  65.3/037.4 77.1 60.2 82.5 38.2 71.4/057.1 
6 (58/F) 56.6 98.3 141.4 69.0 060.3/048.3 85.7 77.2 100.5 36.8 70.4/064.9 
7 (77/M) 63.4 60.9 79.6 31.8 086.5/057.1 82.3 65.2 95.2 49.0 76.8/052.7 
8 (78/M) 54.8 56.1 80.2 41.7 064.6/075.0 58.3 50.6 80.0 48.1 62.9/065.8 
9 (53/M) 82.3 76.6 90.0 21.5 054.5/069.3 81.3 70.2 86.9 30.0 70.0/069.3 








 82.3 80.8 111.0 50.0 64.4/093.5 
11 (61/M) 61.7 68.4 87.9 34.6 069.0/071.9 85.7 68.6 91.7 38.1 53.6/078.0 
12 (69/M) 53.1 72.3 96.6 42.7  35.0/041.5 84.2 84.9 108.4 45.5 23.0/027.3 


























Table 3-2 CABP estimation performance: ITF versus peripheral BP and 
GTF (mean+/-SD). LoA: limits of agreement. 
 ITF Radial BP Femoral BP GTF 
Waveform RMSE [mmHg] 









Systolic BP* Bias [mmHg] 





















  LoA [mmHg] 
3.4.3: Reliability of Identified Tube-Load Model 
In order to gauge the reliability of the identified tube-load models asymptotic 
variance analysis was performed on the identified tube-load model parameters and the 
resulting models as well as the frequency responses of the respective transfer 
functions, the results of which are summarized in Table 3-3. The nominal magnitude 
responses and corresponding confidence intervals of the upper and lower body tube-
load models for subject 1 have been plotted in Figure 3-3 as an example. The estimets 
of the tube-load model parameters made with        were found to be reliable 
with acceptable variance (on the average, less than 16% for     and even smaller for 
the other parameters) but as noted previously     exhibited relatively large variance. 
Despite this large variance in     the overall variance in frequency response is 
reasonably small, indicating that the large variance associated with     does not 
affect the reliability of the overall frequency response of the tube-load model to any 
significant extent. 
 
Table 3-3 Reliability of parallel tube-load models as asymptotic variance (N=2000).  
The asymptotic variance of the tube-load model is quantified at the frequency ω_0 
associated with the peak amplitude response. 
(a) Tube-load model parameters (mean+/-SD) 
                       






















(b) Tube-load model (mean+/-SD) 
   (   )   (   ) 






The relatively large uncertainty of the     parameter can be attributed to its weak 
interaction on the tube-load model’s time- and frequency-domain responses. The 
asymptotic variance analysis showed that the values of asymptotic variance of     
were proportional to the inverse of the calculated nominal value consistently. As an 
example, the sensitivity of the upper-body tube-load model to its parameters (  
 ) for 
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a patient (Subject #1) is shown in Figure 3-3. In this particular patient, the value of 
    was 38.4 for pre-CPB (left panel) and 0.45 for post-CPB (right panel). 
 
 
(a) Nominal amplitude frequency response (solid) and confidence interval (dashed) of 
parallel tube-load model. Left panel: pre-CPB. Right panel: post-CPB. 
 
(b) Parametric sensitivity of tube-load model. Left panel: pre-CPB. Right panel: post-
CPB. 
Figure 3-3 ITF approach: nominal amplitude frequency response, confidence interval 
and parametric sensitivity of parallel tube-load model (Subject #1) 
 
The asymptotic variance analysis yielded important observations in regards to the 
confidences associated with parameter identification and overall model confidence, 
these observations are as follows: 
1. As indicated by Figure 3-3 the tube-load model frequency response is highly 
sensitive to the PTT which is in accordance with previous studies [44] and 
[45]. 
 
2. The sensitivity functions converge to zero as frequency approaches zero 
therefore the tube-load model loses its dependence on its parameters in the 
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low-frequency region. This observation is further back by (25) which 
indicates that tube-load model approaches a value of unity at zero frequency.  
 
3. It is observed that the tube-load model’s frequency response sensetivity to     
and     is larger than its sensitivity to     and     in the mid- to high-
frequency region. The sensitivity of   (  ) to     and     are given by: 
    (  )
    
 
   ( 
           )
[(      )               ] 
   (  )
    
 
(      )( 
           )
[(      )               ] 
 (43) 
which demonstrates that |
   (  )
    
|  |
   (  )
    
| as    . The heart produces 
frequency content in the range of approximately 0.8-3.2 Hz for the left panel 
and 1.3-5.2 Hz in the right panel of Figure 3-3 (comprised of the principal 
harmonic (heart rate) and the first 3 harmonics [5]) which corresponds the 
mid-frequency range in which |
   (  )
    
|  |
   (  )
    
| holds. Due to the range of 
frequency content produced by the heart it is expected that the asymptotic 
variances of     and     is smaller when compared to the asymptotic 
variances associated with     and    .  
4. Inspection of the left (        ) and the right (        ) panels of Figure 
3-3 shows that the sensitivity of the tube-load model’s frequency response to 
    is relatively small in the frequency envelope produced by the heart when 
it assumes small nominal value. Although it is expected that the asymptotic 
variance associated with     will be relatively large when the nominal value 
is small, it was observed that for subset of data in which         (which 
amounts to approximately 50% of the data analyzed in this study), the 
asymptotic variance was only 8.5% of the nominal value on the average, 
indicating the importance of the nominal value and significantly higher 
confidence levels if the condition is met that this nominal value is not 
extremely small. 
The most important factor in estimating CABP is the overall confidence in the tube-
load models which was found to be satisfactory; this can be attributed to the high 
reliability in the parameters excluding     (Table 3-3 and also Figure 3-3). Given the 
reliability of the tube-load model, it can be argued that     is identified with limited 
confidence due to its relatively negligible influence on the dynamic input-output 





In this chapter, by building on material from chapter 2, a two tube-load model of the 
human arterial tree was presented and described mathematically. Next the ITF 
approach was introduced and a thorough treatment of the identification procedure and 
identifiability criteria was presented. The ITF approach was implemented on data 
measured in-vivo from humans and the efficacy and accuracy of the estimated CABP 
along with confidences and variances associated with the identified parameters 
characterizing the arterial tree model was presented and preliminary evidence that the 
ITF approach may be valid for applications in humans was presented. This chapter 
demonstrated that the ITF methodology can accurately and reliably estimate the 
CABP and is indeed subject specific and does not need any a priori information in 
regards to the patient to achieve the CABP estimates.  
 
3.6: Limitations and Future Work 
In this study it was demonstrated that the ITF approach is capable of reproducing the 
CABP accurately, reliably and subject specifically. Future efforts that can be 
conceived to improve the ITF approach are as follows: 
1. This chapter and previous study [25] highlighted that the success of the ITF 
approach is dependent on the frequency content of the signals that it utilizes to 
perform system identification. It was also observed that the frequency range 
that the heart produces contains a limited amount of frequency content so it is 
proposed that a possible solution is to apply an actuation to the arterial tree so 
that combined with its inherent actuation (i.e., arterial BP) the arterial tree is 
subject to rich and informative excitation. Chapter 4 is dedicated to this 
central concept.  
 
2. The ITF approach validated in this thesis utilized invasively measured 
peripheral blood pressures. The efficacy of the ITF approach utilizing non-
invasive arterial waveform measurements remains to be examined. Potential 
measurements that can yield noninvasive peripheral BP measurements are BP 
cuff oscillations [47] and [48] and photoplethysmography signals [49] but it is 
also known that the waveforms measured by these techniques is 
morphologically different from the underlying arterial BP waveform due to 
nonlinear arterial compliance and viscoelastic tissue properties (see, e.g., 
[50]). One possible resolution is to incorporate the non-invasive pulse 
waveforms in the ITF approach by extending the asymmetric two tube-load 
model of the arterial tree to also incorporate mathematical models of the 
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viscoelastic behavior of tissue and arterial dynamics and possibly the sensor 
itself. With the inclusion of these dynamics the identification formulation and 
deconvolution procedure can further be expanded to incorporate these 
peripheral noninvasive measurements. 
 
3. The application of the ITF approach in a clinical setting can be in deriving 
cardiovascular risk parameters such as augmentation index [15], reflection 
magnitude and index [51] as well as aortic dP/dt [52] which can be derived 
from the cardiovascular system model and CABP. The applicability of the ITF 
methodology in deriving these risk parameters with clinically meaningful 
accuracy is of significant importance and our preliminary study to this end 
showed promise [53]. However, intensive assessment on the clinical utility of 














Chapter 4 - Active Noninvasive System Identification of the 
Human Arterial System 
4.1: Introduction to Active Noninvasive System Identification with 
Application to the Asymmetric Tube-Load Model 
In chapter 3 the “Individualized Transfer Function” (ITF) approach was validated 
with experimental data in humans. ITF represents an important step in the estimation 
of robust and reliable as well as subject specific CABP and allows for the potential 
improved cardiovascular health monitoring. Despite the strengths of ITF, it has been 
found that the technique suffers from limited persistent excitation (PE) due to the fact 
that the system identification procedure being implemented in the cardiovascular 
system. The blood pressure waveforms produced by the heart that propagate through 
the arterial tree are not, in general, rich enough to sufficiently excite the CV system 
extensively. Hahn et al. [25] proposed a quality measure that can be used to assess the 
model integrity based on the input signal design in the context of SYSID theory. 
However, unless active external perturbation is applied to the CV system, ITF 
inevitably suffers from the passive SYSID outcomes in that the fidelity of the arterial 
tree model depends significantly on the input-output data created in the CV system 
(i.e. central aortic and peripheral BP waveforms created by the heart). Moreover, once 
non-intrusive approaches are conceived for measuring the hemodynamic waveforms, 
additional complexity is incurred in implementing ITF due to the dynamics associated 
with sensors and the mechanics of tissues that can potentially exhibit highly nonlinear 
behaviors. Regardless, the challenges associated with non-intrusive ITF paradigm 
have rarely been investigated in the existing research efforts. 
In this chapter a novel active non-intrusive system identification procedure to 
cardiovascular health monitoring is introduced. This approach utilizes a dual blood 
pressure cuff setup for the purpose of a collocated actuator sensor system in which 
actuation of the arterial tree will simultaneously be performed with measurement of 
internal (produced by the heart) and external (produced by the actuation of the blood 
pressure cuff) BPs. In this paradigm the purpose of the actuation is to produce rich 
transmural blood pressures to facilitate the system identification of the arterial tree. 
To this end a mathematical model of the propagation of arterial and cuff induced 
blood pressures through the arterial tree is developed and this model was used to 
study the effects of cuff maneuvers on transmural pressures and also to develop a 
methodological framework for the reconstruction of the transmural pressure 
waveforms from cuff oscillation measurements. In this chapter it will be 
demonstrated that the cardiovascular system can be excited noninvasively by active 
cuff maneuvers and that the transmural arterial blood pressures can be reconstructed 
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accurately by judicious processing of the cuff pressure oscillations. Next it is 
demonstrated that using noninvasively measured arterial blood pressures the ITF 
methodology can successfully be implemented to produce accurate and robust 
estimates of the central aortic blood pressure. In the final part of this chapter a system 
identification mathematical framework and system identification protocol is 
developed to utilize rich transmural blood pressures induced by the actuation of the 
blood pressure cuffs to produce accurate and robust noninvasive estimates of the 
central aortic blood pressures. Finally it is noted that the material comprising this 
chapter where previously presented in [60] and [61]. 
 
4.2: Preliminaries to Active Noninvasive System Identification 
Approach 
The cardiovascular system is actuated by laterally propagating BP waves that excite 
arterial vessels radially. In the absence of any extra-vascular excitation source, the 
arterial BP waveform is the only source of excitation for the CV system but it is know 
that this signal is seriously limited in frequency contents (see Figure 4-1a). Therefore, 
it is highly likely that arterial BP wave cannot yield rich input-output data appropriate 
for CV SYSID. The proposed methodology dubbed the Active Non-intrusive CV 
SYSID approach aims to resolve the challenge of limited frequency content by 
externally exciting the arterial tree to obtain rich trans-mural pressure waves that 
propagate through the CV system (see Figure 4-1b). The central theme is to consider 
that the CV system is modeled as a wave propagation system that is excited by the 
trans-mural pressure (the difference between intra and extra-vascular pressures) 
acting on the arterial tree, and given this if extra-vascular pressures is properly 
designed and super-imposed upon the arterial BP wave then this methodology can 
potentially yield persistently exciting trans-mural pressure waves that can 
significantly enhance the efficacy of CV SYSID by providing additional frequency 
content. It is noted that the CV system under external excitation can be regarded as 
the more general case of that of the nominal CV system under the assumption that the 
linear superposition principle holds and it is noted that Figure 4-1a can be obtained 
from Figure 4-1b simply by removing the extra-vascular excitation. 
4.3: Modeling of Pressure Waveform Propagation 
The pressure waveforms produced by the heart and by the blood pressure cuff 
propagate both through the arterial tree and through tissue and cuff material. There is 





Figure 4-1 Cardiovascular SYSID Using Rich Transmural Pressure Waveforms Via 
Active and Noninvasive Extra-Vascular Excitation 
4.3.1: Pressure wave propagation in the CV system (arterial tree): 
In this preliminary feasibility study, we used the asymmetric T-tube model [29] to 
model the behavior of arterial tree and its wave propagation mechanics in response to 
the intra- and extra-vascular pressures. The upper and lower-body circulations are 
modeled by uniform lossless transmission lines terminated with Windkessel-type 
loads. In this setup the CV system is driven by 2 inputs: 1) the central aortic BP    
created by the heart and 2) the extra-vascular excitation pressures     and     acting 
on the upper- and lower-body locations. The arterial pathways for wave propagation 
are characterized by the reflection coefficients at the peripheral ends    and    which 
are defined by (8), the PTT of each tube    and    and the reflection coefficient at the 
proximal ends ( ) which are assumed to be unity. This assumption is made based on 
the state of the aortic valve where during full closure it is hypothesized that perfect 
reflection occurs but this approximation may not be realistic for systole. Finally in 
order to calculate transmural blood pressures the extra-vascular pressures and the 
intra-vascular pressures at proximal and peripheral locations are subtracted at their 
respective locations (denoted as      ,       and       in Figure 4-2). 
The trans-mural pressure at any location in the CV system is contributed by the intra-
vascular (arterial) BP and the extra-vascular excitations applied at peripheral 
locations: 
                      (44) 
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where    is the intra-vascular pressure, while       and       are the extra-vascular 
pressures due to the excitation applied to upper- and lower-body peripheral locations, 
respectively. From the development in chapter 2 the relationship among   ,    and    
can be expressed in terms of PTT    and reflection coefficient   : 
 
  ( )    ( )  ( )  
    ( )
            ( )
  ( )
  ( )    ( )  ( )  
    ( )
            ( )
  ( )
 (45) 
where   ( ),       are the transfer functions dictating the propagation of pressure 
waves whose reflections occur at the peripheral location  . In order to develop wave 
propagation equations for the extra-vascular excitation     we note that     is 
essentially the forward wave component of the total extra-vascular wave that travels 
towards the heart, it is subsequently reflected at the heart due to the aortic valve and 
propagates back to the peripheral excitation location. Due to the assumption that the 
tubes are lossless,     is simply delayed by PTT when it arrives at the heart (    
    ) 
and the backward (reflected) component of the extra-vascular wave at the heart is 
assumed to be the same as its forward counterpart due to the assumption that wave 
reflection at the heart is perfect (     
         
    ). The backward extra-vascular 
wave thus obtained is delayed by PTT when it arrives back at the peripheral 
excitation location (    
     ). 
Consequently, the composite extra-vascular wave at each peripheral location that is 
incurred by the excitation at the corresponding location can be expressed as follows: 
      ( )     ( )(   
     )
     ( )     ( )(        )
 (46) 
Finally, extra-vascular excitation created by an external source in one tube not only 
impacts the trans-mural pressure at the proximal end of the corresponding tube, but 
also propagates to and affects the other tube as follows. First,     propagates to the 
heart location to yield forward and backward waves that are identical, i.e.     
    . 
Therefore, the composite extra-vascular wave at the proximal end of the tube incurred 
by     is      
     (see Figure 4-2): 
           ( ) 
    
          ( )     
 (47) 
These composite waves are then mapped to the peripheral ends of the other tubes via 
the transfer functions   ( ) and   ( ): 
         ( )      ( ) 
    






Figure 4-2 Propagation of intra- / extra-vascular BP in cv system approximated by t-
tube model 
The expressions for the trans-mural pressures at proximal and peripheral ends (i.e. 
     ,       and      ) can be obtained by substituting Equation (45) through 
Equation (48) into Equation (44): 
               
          
     
        ( )[        
    ]     (   
     ) 
        ( )[        
    ]     (   
     ) 
(49) 
where the Laplace variable   for all the pressure variables was omitted for the brevity 
of expressions. Note that all     terms in Equation (49) are AC waveforms;     
cannot propagate otherwise. 
4.3.2: Pressure wave propagation in Tissue and BP Cuff 
In this study, a dual BP cuff is used as an actuator to excite CV system and as a 
pressure transducer to measure trans-mural pressure waveforms at the peripheral ends 
of upper- and lower-body circulations where extra-vascular excitations are applied. 
Essentially, active BP cuff maneuver propagates into the artery through the tissue in 
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order to yield persistently exciting trans-mural pressure wave in the arterial tree. 
Besides, the oscillation of the arterial BP wave at the level of arterial vessel (i.e. 
arterial BP waveform) is measured by the BP cuff as small-amplitude oscillations in 
the cuff pressure recording (see Figure 4-3). 
In order to reproduce the dynamic behavior of a BP cuff as well as the propagation of 
pressure waves between the cuff and the artery through the tissue, a physics-based 
model developed by Ursino and Cristalli [55] was extended and integrated with the 
arterial tree model in Equation (44)- Equation (49) so as to account for the effect of 
extra-vascular excitation (see Figure 4-4). 
 
Figure 4-3 Interaction between artery, tissue and BP cuff: cuff pressure is the sum of 
excitation pressure of cuff and intra-vascular (arterial) pressure propagated to cuff 
through tissue 
The cuff and tissue model for a tube   receives the equivalent intra-vascular pressure 
(which includes the effects of arterial BP, the extra-vascular pressure applied at the 
peripheral end of other tube and the extra-vascular pressure applied at the peripheral 
end of the tube) from the arterial tree model and the active cuff maneuver   ( ) as 
inputs to yield the cuff pressure     as well as the extra-vascular pressure     that is 




Figure 4-4 Model of integrated artery-tissue-cuff system (illustrated for lower-body 
circulation) 
4.4: Active Noninvasive CV System Excitation 
It was demonstrated in a previous study by Hahn et al. [25] that the efficacy of CV 
SYSID, i.e. the quality of the transfer functions   ( ) and   ( ) obtained from 
SYSID, depends on the input property and the underlying physiologic condition of 
the arterial tree. Specifically, it depends on how well the input (BP wave with its 
major frequency contents at heart rate) can excite the arterial tree at the frequency 
envelope associated with high parametric sensitivity. Generally, this frequency 
envelope is not known until SYSID yields   ( ) and   ( ). Regardless, it was 
suggested [25] that the frequency corresponding to heart rate is most often not high 
enough to excite the high-sensitivity frequency envelope effectively. Considering that 
arterial BP has a few harmonics that are significant in amplitude in addition to its 
fundamental heart rate frequency, the active extra-vascular excitation provided by the 
cuff must consist of relatively high-frequency components. Since the goal of this 
section is to show the preliminary proof-of-principle of the proposed approach, extra-
vascular excitation in the frequency envelope of 4Hz-8Hz was considered, noting the 
nominal heart rate range of 60bpm-80bpm. In this frequency range, sinusoidal cuff 
maneuver input was applied to yield sinusoidal pressure in the cuff, which then 
propagates through the tissue to apply sinusoidal extra-vascular pressure on the 
arterial vessel (see Figure 4-3). 
4.5: Noninvasive Transmural Blood Pressure Estimation 
To measure trans-mural pressure, both intra-vascular and extra-vascular pressure 
acting upon the arterial vessel must be measured. In the context of the proposed 
approach, intra- and extra-vascular pressures correspond, respectively, to arterial BP 
and active cuff excitation pressure propagated via the tissue to the arterial vessel. 
First, in regards to arterial BP, it has been suggested that the arterial BP waveform 
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can be extracted with acceptable accuracy from the oscillations in cuff pressure under 
constant cuff pressure loading [56]. In this section, we propose to extract the arterial 
BP waveform from the measurement of cuff pressure     (     ) using a high-pass 
filter and calibrate the waveform thus obtained using the systolic, mean and diastolic 
BP measured by BP cuff. The calibration can be accomplished by the following 
relationship: 
   ( )     ̃  
 ( )     ̃  ( )     (50) 
where  ̃   is high-frequency component in    , i.e.     after high-pass filtering,    is 
arterial BP waveform in tube  , and the coefficients    (       ) are obtained by the 
relationship between   ( ) and  ̃  ( ) at their systolic, mean and diastolic values: 
         ̃    
     ̃        
       ̃   
     ̃       
       ̃   
     ̃        
(51) 
where the subscripts  ,  and   denote systolic, mean and diastolic, respectively. 
Second, the extra-vascular pressure is created by the active cuff maneuver. Despite 
highly complex and nonlinear behavior of tissue and its interaction with cuff and 
arterial vessel, it can be proven analytically that the extra-vascular pressure is nearly 
identical to the pressure developed in the BP cuff via active excitation maneuver. 
Considering that the frequency envelope associated with the active cuff maneuver is 
beyond the heart rate and its non-trivial harmonics, the extra-vascular pressure can be 
measured with accuracy by high-pass filtering the cuff pressure recording. 
Once both the intra-vascular and extra-vascular pressures are obtained as described 
above, the trans-mural pressures at the upper-body and lower-body cuff locations can 
be quantified easily by subtracting the extra-vascular from the intra-vascular 
pressures at the respective locations. 
4.6: Excitation Measurement and Protocol Design and Results 
The proposed active non-intrusive approach to CV system excitation and trans-mural 
pressure waveform measurement is implemented in this study with the protocol on 
the dual BP cuff described in detail below. To demonstrate the feasibility of the 
proposed approach and at the same time to keep the simplicity of presentation, active 
non-intrusive cuff excitation in the high-frequency regime is applied only to the 
lower-body circulation in this preliminary study. 
1. Both upper-body and lower-body cuffs are actuated by standard maneuver 
(i.e. fast ramp-like increase of cuff pressure followed by slow ramp-like 
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decrease) so as to measure systolic, mean and diastolic BP values at the 
corresponding locations. 
2. Both upper-body and lower-body cuffs are actuated by applying constant cuff 
pressures and the cuff pressures are measured. The arterial BP waveforms are 
extracted by high-pass filtering the cuff pressure recordings. 
3. Using the systolic, mean and diastolic BP values and the corresponding levels 
in the arterial BP waveforms extracted from the cuff pressure recordings, 
unknown coefficients    (       ) in Equation (50) are determined by 
solving Equation (51). Then the arterial BP waveforms are calibrated via 
Equation (50) to yield intra-vascular pressure waveforms with physically 
relevant scale. 
4. The lower-body cuff is actuated with high-frequency sinusoidal maneuver 
within 4Hz-8Hz envelope, which yields active sinusoidal excitations to both 
upper- and lower-body arterial trees. For both upper and lower-body BP cuffs, 
the intra-vascular pressure waveforms are obtained by applying band-pass 
filtering to the cuff pressure recordings (i.e. by eliminating DC component in 
the low-frequency stop band and the active high-frequency excitation in the 
high-frequency stop band), which is subsequently calibrated using Equation 
(50). The extra-vascular pressure waveforms, on the other hand, are obtained 
by applying high-pass filtering to the cuff pressure recordings. 
5. The trans-mural pressure waveforms associated with upper-body and lower-
body cuff locations are obtained by subtracting extra-vascular waveforms 
from their respective intra-vascular counterparts.  
Utilizing the 5 protocol steps outlined with the cuff maneuver sequence associated 
with the proposed excitation and measurement protocol is illustrated in Fig. 5 and is 
composed of three distinct maneuvers: standard, constant and sinusoidal maneuvers. 
During the standard maneuver, systolic, mean and diastolic BP of upper- and lower-
body circulations are determined. During the constant maneuver, intra-vascular 
pressure waveforms (i.e. arterial BP waveforms) are measured and calibrated. During 
the sinusoidal maneuver, extra-vascular pressure acting upon the lower-body is 
measured, with which trans-mural pressures at both upper- and lower-body locations 
are obtained. To extract the arterial BP and the cuff excitation pressure waveforms 
from the cuff pressure recording, this study employed 9th-order Butterworth band-




Figure 4-5 Cuff maneuver sequence for proposed excitation and measurement 
protocol 
To establish preliminary proof-of-principle of the proposed active and non-intrusive 
SYSID approach, we used a synthetic arterial BP waveform (in mmHg) shown in 
Equation (52): 
 
  ( )          (  
  
  
  )        (  
  
  
      ) 
(52) 
Figure 4-6 compares the trans-mural pressures acting upon the arterial vessels at the 
peripheral ends of upper- (upper panel) and lower-body (lower panel) circulations, 
where the right and left panels show the waveforms in the absence and presence of 
external excitation (4Hz sinusoidal maneuver), respectively. It is obvious that the 
active excitation contributes to create richer and more informative trans-mural 
pressure waves in the arterial tree, which have potential to enhance the quality of CV 
SYSID significantly. 
 
Figure 4-6 Transmural pressure waves acting on arterial vessels in the absence and 




Figure 4-7 Active excitation pressure applied to BP cuff versus extra-vascular 
pressure acting on arterial vessel 
 
Figure 4-8 True versus reconstructed arterial BP waveforms at lower-body location 
Figure 4-7 compares the extra-vascular pressure acting on the arterial vessel and the 
pressure incurred in the cuff by the active excitation, which demonstrates that the 
extra-vascular pressure acting on an arterial vessel (   ) can be measured accurately 
by high-pass filtering the corresponding cuff pressure (   ). In essence, there was no 
delay between the two waveforms. The extra-vascular pressure was different from its 
cuff counterpart only by a constant gain for active cuff excitation maneuvers below 
diastolic pressure level (resulting in positive trans-mural pressures without artery 
collapse). This gain was analytically evaluated to be 0.99 in this study, based on the 
mathematical models describing the dynamics of BP cuff, tissue and arterial vessel. 
Indeed, the root-mean-squared error (RMSE) between extra-vascular and cuff (after 
high-pass filtering was applied) pressures in Figure 4-7 was very small (0.56mmHg). 
Figure 4-8 shows the arterial BP waveform extracted from the cuff pressure 
oscillations in the lower-body location by high-pass filtering (left panel), and the 
corresponding intra-vascular pressure reconstructed via the calibration in Equation 
(50), suggesting that intra-vascular pressure waveform can be reconstructed with 
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accuracy based on BP cuff. RMSE between true and measured intra-vascular 
pressures shown in Figure 4-8 was only 0.57 mmHg, which was only 1.82% of the 
underlying BP level. 
Finally, Figure 4-9 shows true versus reconstructed trans-mural pressure waves at the 
upper-body and lower-body locations. It is important to note that, since the active 
non-intrusive extra-vascular excitation was applied only to the cuff in the lower-body 
location, the trans-mural pressures at the upper-body and lower-body locations can be 
expressed as follows: 
      ( )    ( )[  ( )      ( ) 
    ] 
     ( )    ( )     ( )[   
     ] 
(53) 
Consequently, lower-body trans-mural pressure waveform was obtained by 
subtracting extra-vascular pressure (in Figure 4-7) from intra-vascular pressure (in 
Figure 4-8), whereas upper-body trans-mural pressure was measured directly from its 
cuff pressure oscillations. For the active and non-intrusive excitation scenario shown 
in Figure 4-9 (4Hz sinusoidal maneuver), RMSE between the true versus 
reconstructed trans-mural pressure waveforms were very small; only 3.57 mmHg for 
upper-body and 3.76 mmHg for lower-body locations. Table 4-1 summarizes RMSE 
of trans-mural pressure measurement under active extra-vascular excitation of 
different frequencies, which clearly demonstrates the feasibility and validity of the 
proposed active non-intrusive approach to CV SYSID; rich and informative trans-
mural pressures can be non-intrusively created and measured with fidelity. 
Table 4-1 RMSE of transmural pressure under active excitations under varying 
frequencies 
Excitation Frequency PTM,1 RMSE PTM,2 RMSE 
4Hz 3.57mmHg 3.76mmHg 
6Hz 3.59mmHg 4.27mmHg 
8Hz 4.06mmHg 5.46mmHg 
 
Figure 4-9 True and reconstructed trans-mural pressures acting on upper-body and 
lower-body arterial vessels 
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The most important claims from this section are that trans-mural pressure wave can 
be made more informative for SYSID purposes by actively exciting the extra-vascular 
pressure, and that it can also be measured accurately in the presence of high-
frequency excitation maneuvers. Despite its initial success, this study has a few 
limitations. 
First, the proposed approach was developed based on a simplistic approximation of 
arterial tree (i.e. asymmetric T-tube model extended with extra-vascular excitations). 
In particular, this study neglected secondary wave reflections occurring in CV 
system. Although it is regarded as a reasonable assumption based on a previous study 
on repeated wave reflections in CV system [31], the validity of wave propagation 
model developed in this study must be further investigated experimentally. 
Second, although it is anticipated that an upper bound will exist beyond which active 
extra-vascular excitation is no longer effective due to the nonlinear and viscoelastic 
tissue dynamics, the frequency limit up to which the proposed approach is viable was 
not completely investigated. This study demonstrated the feasibility of the proposed 
active excitation idea in the 4Hz-8Hz frequency envelope (which is sufficiently high 
compared with nominal heart rate levels of approximately 1Hz). However, in-depth 
investigation on the above-mentioned concern must be clearly addressed. 
Third, the excitation and measurement protocol designed in this study may further be 
improved. For example, the use of advanced filtering algorithms may be considered 
to improve the extraction of intra- and extra-vascular pressure waveforms from the 
cuff pressure recordings. Besides, the relationship in Equation (50) used for the 
calibration of intra-vascular pressure may also be improved to achieve superior intra-
vascular pressure waveform measurement accuracy. 
Lastly and most importantly, the effectiveness of proposed active non-intrusive extra-
vascular excitation approach for CV SYSID was not completely demonstrated in the 
current study. It is anticipated at least intuitively that the proposed approach has 
potential to yield superior CV SYSID outcomes with richer and more informative 
input-output data pair (than mere arterial BP waveform) it can provide. The ultimate 
objective of this study was to establish the validity of active non-intrusive CV system 
excitation and trans-mural pressure measurement ideas, and as such, its efficacy in 
regards to CV SYSID was not the primary focus. This aspect will be intensively 




4.7: Passive Noninvasive System Identification and CABP 
Reconstruction 
It is possible to combine the dual blood pressure cuff paradigm developed in the 
previous section with the ITF methodology developed and validate in chapter 3 to 
perform noninvasive ITF, here called Passive Noninvasive ITF (PNITF). In order to 
demonstrate the feasibility of this approach first synthetic data was produced by using 
experimentally measured invasive BP signals collect based on the protocol from the 
previous chapters from patients undergoing cardiopulmonary bypass surgery. The 
peripheral blood pressures (radial and femoral) were applied to Ursino et al. [55] 
mathematical model of blood pressure cuff to generate synthetic cuff pressure data. 
The model consists of the pressure-volume relationship of the cuff bladder, the 
dynamics of the tissues, and the arterial vessel’s hemodynamics. The cuff pressure 
data were then applied to the individualized transfer function algorithm to estimate 
central BP waveform. The protocol outlined in Section 6 to apply to the noninvasive 
ITF methodology as described below: 
The noninvasive individualized transfer function (see Figure 4-10) measures non-
invasive circulatory waveform signals and transforms them to arterial waveform 
signals (STEP 1), adapts its transfer function (i.e., the relationship between diametric 
circulatory signals) to the arterial waveform signals obtained above (STEP 2), and 
estimates the central BP waveform by filtering the non-invasive circulatory waveform 
measurements through a stable de-convolution algorithm (STEP 3). In its 
implementation with a dual diametric cuff system, the BP is first measured through 
the oscillometric procedure, and the cuffs are inflated at an appropriate sub-diastolic 
pressure level to measure the oscillations in the cuff pressures that correspond to the 
arterial pulsations. These pulsatile oscillations are then transformed to arterial BP 
waveforms by calibrating them to systolic, mean and diastolic BPs. Using the 
multiple diametric arterial BP signals thus derived, the individualized transfer 
function is derived by solving the following equation: 
   
  ( )  ( )    
  ( )  ( ) (54) 
Where   ( ) is the ith diametric BP, and   ( ) is the transfer function relating the 
central BP to the ith diametric BP given by: 
 
  ( )  
         
    (     )          
 
(55) 
where    is the pulse travel time (PTT) between central and ith diametric BP, while 
    and     are parameters related to wave reflection at the ith diametric location. 
Finally, the central BP waveform is estimated by processing the diametric arterial BP 
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waveforms by a stable de-convolution filter. In this study, a simple direct inverse 
filtering is used: 
  ̂ ( )      
  ( )  ( )  (    )  
  ( )  ( ) (56) 
where  ̂ ( ) is the estimated central BP, and        is a weighting factor 
(       was used in this study).  The proof-of-principle of the non-invasive 
individualized transfer function was established in terms of the accuracy of its 
estimated central BP and the reliability of the transfer function. The accuracy of the 
central BP was quantified in terms of the root-mean-squared error (RMSE) between 
true and estimated central BP waveforms, as well as the errors between true and 
estimated central systolic and pulse pressures. The reliability of the transfer function 
was quantified by the asymptotic variance of the transfer function parameters 
including PTT and the wave reflection coefficients. 
 
Figure 4-10 Non-invasive individualized transfer function 
Figure 4-11 shows a representative example of the arterial BP waveforms derived by 
the non-invasive individualized transfer function. The first two plots show the 
diametric arterial BPs and their estimates obtained from the cuff pressure oscillations, 
while the third plot shows the true and estimated central BPs. The error statistics for 
16 datasets, constructed from the clinical data of 8 subjects, are listed in Table 4-2. 
The results clearly suggest that the non-individualized transfer function can estimate 
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the central BP with fidelity, and it largely outperforms direct non-invasive peripheral 
BP in its morphologic similarity to the true central BP measurement. 
Table 4-3 summarizes the asymptotic variance of PTT and the reflection coefficient 
parameters. Except     which suffers from relatively large uncertainty, the 
parameters characterizing the individualized transfer function can be regarded as 
reliable with tight asymptotic variance (in terms of standard deviation). 
Figure 4-12 presents a representative example of the individualized transfer 
function’s frequency response together with the amount of uncertainty involved (in 
terms of the confidence interval). It is noted that, despite the large variance associated 
with    , the frequency responses corresponding to both diametric locations exhibit 
small uncertainty (as suggested by their tight asymptotic variances). 
Table 4-2 Accuracy of central BP estimated by the individualized transfer function. 
SP: systolic pressure. PP: pulse pressure 
 RMSE [mmHg] SP Error [mmHg] PP Error [mmHg] 
ITF 4.49 (6.47%) 04.06 (03.97%) 07.96 (18.12%) 
P1 6.02 (8.45%) 11.84 (12.14%) 11.95 (29.23%) 
In fact, the sensitivity of the individualized transfer function to     was very small, 
which justifies its minimal adverse impact on the fidelity of the frequency responses. 
Also note that non-invasively versus invasively determined transfer functions exhibit 
non-negligible discrepancy in their frequency responses, which appears to be mainly 
incurred by the limited fidelity of the arterial pulsations derived from the oscillations 
in the cuff pressure, which must be improved in a follow-up study. 
Table 4-3 Asymptotic variance of individualized transfer function parameters: mean 
(SD). 
   [%]     [%]     [%]    [%] 
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This section demonstrated the preliminary proof-of-principle of the non-invasive 
individualized transfer function approach to estimating central BP waveform from 




Figure 4-11 Diametric and central arterial BP waveforms derived by non-invasive 
individualized transfer function. 
 
Figure 4-12 Frequency response of individualized transfer function with its 
confidence interval as quantified by asymptotic variance analysis. 
4.8: Active Noninvasive System Identification Approach 
In the ITF methodology, the dynamics of the arterial tree is identified using the 
arterial BP wave which excites the arterial vessels in the radial direction. The 
frequency contents of the arterial BP are limited to only a few harmonics of HR, and 
as a consequence, the arterial tree cannot be persistently excited with the arterial BP 
alone. Therefore, arterial BP alone cannot provide informative data to result in high-
fidelity SYSID. 
In the proposed active non-intrusive SYSID paradigm, the arterial tree is excited via 
an external actuator so that an extra-vascular pressure wave is created, which is 
subsequently added to the intra-vascular pressure (i.e. arterial BP) to yield a highly 
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informative trans-mural pressure wave. Then, the rich trans-mural pressure wave thus 
created is measured by the sensor collocated with the actuator. Noting that the arterial 
vessels are essentially excited by the trans-mural pressure wave rather than the 
arterial BP wave alone, extra-vascular pressures properly designed and super-imposed 
upon the arterial BP wave can potentially yield persistently exciting trans-mural 
pressure wave that significantly enhances the efficacy of cardiovascular SYSID. Note 
that nominal CV system not involving any extra-vascular excitation can be regarded 
as a special case of CV system being subject to zero extra-vascular pressure; under 
the assumption that the linear superposition principle holds. 
The goal of the SYSID is to exploit the observations       and       (49) to identify 
the dynamics   ( ) and   ( ) of the CV system, and then to reconstruct the central 
aortic BP   . In this section we demonstrate that this goal can be fulfilled by 
exploiting the commonalty in       and      : they are both affected by the central 
aortic BP   , although it is not known a priori. To exploit this commonality we 
conclude from (49) that: 
      
  [         (   
     )]       
     (57) 
And so we can conclude that: 
     [         (        )]                [         (        )]            (58) 
Further, to clearly illustrate the idea, we consider the scenario in which only one 
actuator (   ) exerts active excitation to the arterial tree (i.e.,      ). In this 
scenario, Equation (49) reduces to: 
         ( )[        
    ]
        ( )      (   
     )
 (59) 
both of which contains   . Thus, solving (59) for    yields: 
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 (60) 
In Equation (60),   ( ) and   ( ) (which are given by Equation (55)) must be 
determined from the observations of trans-mural pressures       and      , and the 
active extra-vascular pressure    . The CV dynamics   ( ) and   ( ) are 
characterized by PTT    and the reflection coefficient    (     ), where    reduces 
to a first-order low-pass filter in case the windkessel-type load terminates the arterial 
conduits: 
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where    ( ) and     are load and characteristic impedances of the conduit,     and 
    are peripheral resistance and terminal compliance, all corresponding to the 
conduit  , and 
 
    
        
          
     
   
          
 
(62) 
Thus, Equation (60) involves six unknowns in total to be identified: 
   {     }    {          }    {          } (63) 
and the following optimization can be constituted to solve the SYSID problem in 
Equation (6): 
          
    
‖  (   )    (   )‖ (64) 
where    is the vector of optimal arterial dynamics parameters, and    is the 
parametric space    belongs to due to its physical implications and constraints: 
    { |                     } (65) 
Indeed, PTT,     and     must be positive by definition. Also,          is obvious 
from Equation (62). It is emphasized that the availability of     is not a trivial 
proposition, because     is the active excitation at the extra-vascular level but it is 
noted that estimation of     has been discussed in Section 6. 
 
Figure 4-13 Model-based setup: integrated artery-tissue-Collocated actuator-sensor 
system 
In this preliminary study, the feasibility of the proposed active non-intrusive CV 
SYSID methodology is validated in a model-based simulation experiment. The 
model-based setup is depicted in Figure 4-13, which consists of (i) the wave 
propagation in the arterial tree given by Equation (49), (ii) the change in the area of 
the arterial vessels due to varying trans-mural pressure and its subsequent propagation 
through the tissue to the skin, and (iii) the dynamics of the collocated actuator-sensor 
system (where a dual BP cuff is used as a prototype collocated actuator-sensor system 
in this preliminary study; see below for details). 
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In this study, a dual BP cuff is used as a prototype device for the collocated actuator-
sensor system. As shown in Figure 4-13, BP cuffs are placed at the arm and leg 
locations to provide the excitation and observe the trans-mural pressures in these 
locations. The air flow   ( ) provided to the cuff controls the cuff pressure, which is 
subsequently propagated through the tissue to the arterial vessel and act as an active 
extra-vascular excitation    ( ). This extra-vascular pressure propagates along the 
arterial tree, and is also super-imposed to the intra-vascular pressure (i.e., arterial BP) 
to yield the trans-mural pressure that persistently excites the arterial vessel (i.e., 
deforms in the radial direction) via nonlinear arterial compliance characteristic. The 
change in the arterial vessel area propagates through the tissue back to the cuff, which 
is finally observed as small-amplitude oscillations in the cuff pressure [57]. 
In this study, a physics-based model of the BP cuff and the dynamics of the arterial 
vessel loaded by the cuff developed by Ursino and Cristalli [55] was extended and 
integrated into the model of wave propagation in the arterial tree in Equation (49) to 
constitute the model-based setup to validate the proposed CV SYSID paradigm, 
which is capable of reproducing the dynamic behavior of the BP cuff, propagation of 
pressure waves between the cuff and the arterial vessel through the tissue, as well as 
the interaction between intra- and extra-vascular pressures. In the integrated model, 
the cuff maneuver is allowed to travel in the arterial tree with reflections as extra-
vascular pressure, and the observed cuff pressure is allowed to accommodate the 
effects of the reflected extra-vascular pressures as well as the arterial BP. 
For the purpose of model-based simulation experiment, the arterial BP waveforms 
collected from cardiac surgery patients were used. Specifically, central aortic and 
peripheral (radial and femoral) BP waveforms were collected from eight patients both 
before and after the cardio-pulmonary bypass (CPB), and were used to identify the 
dynamics of the arterial tree   ( ) and   ( ) corresponding to each patient. These 
identified dynamics were then used to simulate each patient with the corresponding 
peripheral BP waveform data, thereby creating the trans-mural pressures via Equation 
(59) (where      ( )  ,       was used): 
             ( )    
    
            (   
     )
 (66) 
Now the systematic procedure for the active non-intrusive CV SYSID methodology 
proposed in this study is summarized. The protocol required on the collocated 
actuator-sensor system to carry out the SYSID is depicted in Figure 4-5. 
As  noted previously in case of the “passive” ITF (the ITF based on the arterial BP 
alone), the quality of the CV SYSID heavily depends on the arterial BP (especially 
the HR) and the physiologic state of the arterial tree [25]. In particular, it was 
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observed that the arterial BP has limited capability to persistently excite the CV 
system, because the HR is typically lower than the frequency range in which the CV 
system dynamics   ( ) and   ( ) exhibit high parametric sensitivity. In this regard, 
the active excitation must complement the arterial BP by exciting the CV system in 
the relatively high frequency range to enhance the SYSID. On the other hand, the 
upper bound of the frequency associated with active excitation inevitably exists due 
to the limited bandwidth of the actuator. Noting that the arterial BP possesses up to a 
few significant harmonics [20], the active excitation was provided to the arterial tree 
in the frequency band of 20 Hz-35 Hz. In this band, the excitation maneuver was 
designed as the sum of ten sinusoids with random amplitudes and phase angles.   
To outline the estimation of the transmural blood pressures at the peripheries we note 
that by definition, the trans-mural pressure is the difference between the intra-
vascular and the extra-vascular pressures. In the context of the proposed SYSID 
methodology, the intra- and the extra-vascular pressures correspond to the arterial BP 
and the active excitation, respectively. Therefore, in order to derive the trans-mural 
pressure, both arterial BP and active excitation pressure must be determined from the 
available observations.  
The cuff pressure     observed by the BP cuff consists of two components: the large-
amplitude oscillation corresponding to the active excitation, and the small-amplitude 
oscillation that represents the change in the arterial vessel area in response to the 
combined intra- and extra-vascular pressures acting on the arterial vessel. In case of 
the lower-body circulation, Equation (12b) can be decomposed into the following 
three components: 
         ⏟
( )
    ⏟
(  )
     
     ⏟   
(   )
 (67) 
where (ii) is the forward (i.e., traveling to the heart) component of the extra-vascular 
pressure created by the active excitation, whereas (iii) is its backward component 
traveling back to the lower-body periphery from the heart resulting from the forward 
component reflected at the heart. Therefore, (ii) can be inferred from the large-
amplitude oscillation in     while (i) and (iii) are included in the small-amplitude 
oscillation in    . Considering that     is nearly identical to the large-amplitude 
component of     [34], and that     is essentially known a priori through the designed 
active excitation maneuver, the remaining challenge in reconstructing       is to 
separate and properly calibrate (i) and (iii) from the small-amplitude component of 
   . 
This study proposes the following step-by-step procedure to reconstruct the trans-
mural pressure      . Firstly, the large-amplitude component of     is extracted to 
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yield (ii). Secondly, the remaining small-amplitude component is band-pass filtered 
(with the low-frequency stop band to eliminate the DC and the high-frequency stop 
band to eliminate the active extra-vascular pressure) to derive the cuff pressure 
oscillation associated with the arterial BP, which is subsequently calibrated by (50) to 
yield the arterial BP (i) in the lower-body measurement site. Thirdly, the small-
amplitude component is high-pass filtered to derive the cuff pressure oscillation 
associated with the reflected active excitation from the heart, which is scaled to have 
the amplitude identical to its forward counterpart (based upon the assumption that the 
conduit is lossless). Finally,       can be reconstructed by subtracting (ii) and (iii) 
from (i) as dictated in Equation (67). 
Similarly to the lower-body case, in case of the upper-body circulation, Equation 
(12a) can be decomposed into two components: 
         ⏟
( )
    ( )    
    ⏟     
(  )
 (68) 
where (ii) is the extra-vascular pressure, or the active excitation applied to the lower-
body that has propagated to the upper-body circulation. Noting that there is no direct 
active excitation at the upper-body BP cuff, both (i) and (ii) in Equation (68) are 
included in the small-amplitude component of    . Therefore, the trans-mural 
pressure       can be reconstructed using the following procedure. Firstly, the small-
amplitude component is band-pass filtered (with the low-frequency stop band to 
eliminate the DC and the high-frequency stop band to eliminate the active extra-
vascular pressure) to derive the cuff pressure oscillation related to the arterial BP, 
which is subsequently calibrated by (50) to result in the arterial BP (i) in the upper-
body measurement site. Secondly, the small-amplitude component is high-pass 
filtered to derive the cuff pressure oscillation related to the propagated active 
excitation from the lower-body through the heart, which is scaled to have the 
amplitude identical to     (based upon the assumption that the conduit is lossless). 
Finally,       can be reconstructed by subtracting (ii) from (i) as shown in Equation 
(68). 
In implementing the above procedures for reconstructing the trans-mural pressures, 
nonlinearity associated with the BP cuff imposes a subtle challenge as to how to 
choose the pass band of the band-pass filter for deriving the arterial BP. Indeed, 
undesired harmonics are introduced to the frequency spectrum of the small-amplitude 
component of the cuff pressures     and     through the nonlinearity inherent in the 
BP cuff. It then distorts the frequency spectrum responsible for the arterial BP, 
making it difficult to discern the frequency contents associated with the arterial BP 
from those artifacts that are incurred by the BP cuff. In this study, two alternative 
approaches are proposed to resolve this challenge: (i) to retain a pre-specified number 
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of harmonic components in the cuff pressure oscillation, or (ii) to select the upper 
bound of the pass band of the band pass filter (used to extract the arterial BP) as the 
frequency at which the signal energy becomes a pre-specified fraction of the signal’s 
total energy, and the harmonics below the selected bound are used to reconstruct the 
arterial BP, whereas those beyond it are regarded as artifacts and are thus discarded. 
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(69) 
Once the trans-mural pressures are reconstructed, the CV SYSID problem can be 
solved to identify the arterial dynamics by solving Equation (70). Since the trans-
mural pressures are given as discrete-time sequences, Equation (64) is re-formulated 
in the time domain as follows. First, both the right-hand side and the left-hand side of 
Equation (64) are written into the discrete-time difference equations shown in 
Equation (69) (see the top of the page) via the forward difference approximation 
    (   ), where   is the discrete-time forward shift operator and    is the data 
sampling frequency. Second, for a given vector of unknowns  , the time series 
sequences of the new variables   ( ) and   ( ) are calculated by substituting      , 
      and     into Equation (69). Third,   is optimized so that the discrepancy 
between   ( ) and   ( ) is minimized: 
          
    
‖  (   )    (   )‖ (70) 
It is noted that the optimization in Equation (16) is not a trivial problem, because it 
involves the identification of both model structure and the model parameters. Indeed, 
the values of PTT    [    ] and    [    ] (where [ ] returns the integer that is 
nearest to its argument) are not known a priori and must be identified together with 
the model parameters. Exploiting the fact that the arterial wave propagation dynamics 
are much more sensitive to the PTT than the remaining parameters [58], the SYSID 
problem formulated by Equation (70) is solved using a two-stage optimization 
problem: Equation (70) is solved multiple times over a physiologically relevant range 
of PTT (two-dimensional space spanned by    and   ), and the optimal set of 
parameters,   , is determined as the one with the smallest norm: 
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subject to      and        . 
 
Figure 4-14 Measured versus Calibrated Peripheral ABPs 
Figure 4-14 shows measured versus calibrated BP waveforms at the arm (left panels) 
and the leg (right panels) sensor sites, which illustrates that the empirical polynomial 
relationship in Equation (13) is effective in calibrating the cuff pressure oscillation to 
the arterial BP as well as to alleviate the nonlinear distortion induced by the BP cuff, 
once the frequency components in the cuff pressure oscillation responsible for arterial 
BP are properly separated from the harmonics due to the nonlinear artifacts of the BP 
cuff (which is discussed below; see also Figure 6).  
Figure 4-15 depicts (i) the adverse impact of the nonlinearity in the BP cuff on the 
frequency spectrum of the arterial BP waveform and (ii) the effectiveness of the 
proposed approach to reject the artifact. The left two panels of Figure 4-15 indicates 
that the nonlinearity associated with the BP cuff introduces drastic distortions in the 
harmonic components, beyond 7 Hz and 4 Hz for     and    , respectively. The right 
two panels of Figure 4-15 compares the actual arterial BP with its reconstructed 
counterparts by (i) retaining the pre-specified number of harmonic components in the 
oscillation in     (here, six and seven were used for arm and leg sites, respectively, as 
shown with the gold vertical lines) as proposed above and (ii) a brute-force low-pass 
filtering with 20 Hz cut-off frequency. It is obvious that fidelity of the reconstructed 
arterial BP can be significantly improved with the proposed than the brute-force 
approach. Although not shown, the alternative approach based on the fractional signal 
energy criterion resulted in arterial BP with comparable fidelity. It was observed that, 
on average over the eight subjects, retaining (i) six and seven harmonics for arm and 
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leg locations, or (ii) frequency contents corresponding to 90% and 95% of the total 
energy for arm and leg locations, respectively, yielded satisfactory performance in 
reconstructing the arterial BP from cuff pressure oscillations. 
  
Figure 4-15 Rejection of Nonlinear Artifact of the Cuff and Reconstruction of ABP 
Waveforms 
The actual versus reconstructed trans-mural pressures are shown in Figure 4-16 for 
arm (upper panel) and leg (lower panel) locations. Compared with the pure arterial 
BP in the absence of any active extra-vascular excitation pressures (see, for example, 
Figure 4-15), the active excitation contributed to create richer and more informative 
trans-mural pressure waves traveling in the arterial tree, which have potential to 
enhance the quality of CV SYSID significantly. The unique strength (and in fact a 
subtle challenge as well; see the Limitation of Study Section for details) of the 
proposed approach to reconstruct the trans-mural pressures is that it does not require a 
priori knowledge on the PTT    (which is not supposed to be available until SYSID is 
performed, unless additional measurements are provided) when separating the intra-
vascular from the extra-vascular pressures. 
Finally, the actual versus reconstructed central aortic BP waveforms are presented in 
Figure 8. The reconstructed central aortic BP was derived as follows (see Equation 
(69) for    and   ): 
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where         (in this study,       
 
 
 was used). It is obvious that the 
proposed active non-intrusive methodology for CV SYSID could successfully 
reconstruct the central aortic BP with fidelity (see Table 4-4 for the root-mean-
squared waveform error (RMSE), errors in systolic and pulse pressures, and the r2 
value), which supports its preliminary proof-of-principle and potential as a viable 




Figure 4-16 Actual versus reconstructed transmural pressure waveforms for CV SYSID 
Finally, the active non-intrusive SYSID is compared with its passive counterpart and 
the direct peripheral BP (the radial BP was considered due to its routine availability in 
real clinical setting). Since the primary focus is the ability of the alternative 
approaches to estimate the central aortic BP, the comparison was made in terms of the 
errors associated with the accuracy of the central aortic BP waveform. Table 4-4 
clearly shows that the proposed active SYSID outperforms the passive SYSID as well 
as the direct radial BP. For all the error metrics compared, the active SYSID resulted 
in smaller bias and tighter variance. The r2 value was also higher in the active than in 
the passive SYSID and the radial BP. Although the statistical significance was not 
established in this preliminary study due to the limited number of cases, Table 4-4 
strongly assures the superiority of the active non-intrusive SYSID approach to its 
passive counterpart. 
 
Figure 4-17 Actual versus reconstructed central aortic BP waveforms 
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Table 4-4 Comparison of active non-intrusive SYSID, passive non-intrusive SYSID 
and direct radial BP in estimating central aortic BP (mean±SD) 






Active SYSID 3.31±1.28 0.06±3.97 1.36±4.44 0.93±0.06 
Passive SYSID 4.12±2.02 2.67±5.99 1.59±6.76 0.84±0.15 
Radial BP 5.32±1.77 -8.55±10.77 -7.79±12.95 0.90±0.07 
This study clearly demonstrated that the proposed active non-intrusive CV SYSID 
methodology has potential to result in enhanced CV SYSID outcomes than its passive 
counterpart (i.e. SYSID based upon the arterial BP alone) with richer and more 
informative transmural BP it can provide. Despite its overall success, this study has a 
few limitations. 
First, the methodology was developed based upon a rather simplistic representation of 
the arterial tree: uniform lossless conduits connected in parallel to approximate upper- 
and lower-body circulations. In particular, this study neglected secondary wave 
reflections (called “re-reflections”) known to occur in the arterial tree [29]. Further, 
this study implicitly assumed that the peripheral collocated actuation-sensing sites 
correspond to the terminal locations of the conduits, and that the actively excited 
extra-vascular pressure waves travel only to the heart, but not to further down the 
extremities. The validity of these simplifying assumptions must be investigated 
experimentally. 
Second, in-depth study on the optimal active excitation is desired, in terms of both 
frequency range and amplitude of the excitation. Although the use of rather 
empirically selected band and amplitude of 20 Hz-35 Hz and 5 mmHg was 
efficacious in this study, we anticipate that the excitation of excessively high 
frequency range may not be effective due to the nonlinear and viscoelastic nature of 
the tissue mechanics, and also, too much increase in the amplitude of excitation may 
trigger the intrinsic CV control mechanism (the autonomic baroreceptor control). In 
this regard, more systematic understanding on the relationship between the active 
extra-vascular excitation and the resulting SYSID outcomes must be established. 
Third, in separating the large-amplitude oscillation from its small-amplitude 
counterpart in    , a critical assumption was made: that the large-amplitude 
oscillation corresponding to the active excitation is completely known by the input 
maneuver to the actuator (i.e. the open-loop input-output relationship of the actuator 
is known without uncertainty). This assumption may only be justified with the 
availability of highly accurate model of the actuator. In the future study, efforts to 
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improve the trans-mural pressure estimation and/or the SYSID procedure to relax the 
above rather restrictive assumption must be made. 
In conclusion this chapter presented the development and the preliminary proof-of-
principle of an innovative active non-intrusive SYSID methodology for CV 
monitoring. The methodology uses a dual collocated actuator-sensor system to 
actively excite the arterial tree and create rich and informative trans-mural pressure 
waves (actuation), and also to observe the trans-mural pressure waves non-intrusively 
(sensing). This study discussed algorithms to (i) estimate the trans-mural pressure 
waves and to (ii) identify the CV system dynamics based on the trans-mural pressure 
waves thus estimated. It was illustrated that the SYSID algorithm was able to 
accurately reconstruct the central aortic BP, and that its performance was superior to 
the passive non-intrusive approach with statistical significance. It is anticipated that 
the proposed active non-intrusive SYSID paradigm will enhance our ability to 

















Chapter 5 – Conclusions and Future Directions 
5.1: Conclusions and Summary 
This thesis aimed to introduce a noninvasive cardiovascular health monitoring 
methodology employing blood pressure cuffs and demonstrate its feasibility. In order 
to accomplish this goal: 
 In chapter two the tube-load model was introduced and described 
mathematically in its single and double tube manifestations. It was 
experimentally demonstrated that the tube-load model is capable of describing 
accurately and reliably the relationship between central and peripheral blood 
pressures in humans using invasively recorded data from humans undergoing 
surgery. The tube-load model serves as the foundation for health monitoring 
techniques described in this thesis and its validation in humans is of the 
utmost importance. Prior to this study the authors have no knowledge of an 
extensive quantative validation of the tube-load model in humans so as a first 
step toward the development of successful health monitoring techniques this 
step was deemed important. 
 In chapter three the individualized transfer function (ITF) methodology was 
presented and mathematically described. The ITF methodology uses two 
diametrically opposed peripheral blood pressure waveforms to estimate the 
central aortic blood pressure waveform. Many studies indicate that the central 
aortic blood pressure waveform plays an important part in evaluating 
cardiovascular health and that peripheral arterial blood pressures are not 
adequate replacements. In order to validate the ITF methodology invasively 
recorded data measured at the central aortic, radial and femoral arteries was 
utilized and a commonality of the pressure waveforms measured at the 
peripheries (i.e. the radial and femoral blood pressures) was exploited to 
reproduce an estimate of central aortic blood pressure using the tube-load 
model validated in chapter 2. This thesis demonstrated that central aortic 
blood pressure could accurately, reliably and robustly be estimated in a 
diverse set of hemodynamic conditions and that the estimate outperformed the 
estimation made by the peripheral blood pressures used as surrogates to the 
central aortic blood pressure. 
 In chapter four an active noninvasive individualized transfer function was 
introduced and described mathematically. The purpose of this newly proposed 
methodology is to overcome some of the inherent limitations of the ITF 
methodology, i.e. the invasive nature of the measurements of the peripheral 
blood pressures and also the lack of frequency richness in the central aortic 
blood pressure produced by the heart. The proposed methodology utilized a 
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dual blood pressure cuff system to simultaneously noninvasively measure 
peripheral blood pressures and actuate the arterial tree to create rich 
transmural blood pressures to improve the quality of the signals for the 
purposes of system identification. It was demonstrated in this feasibility study 
that this methodology is capable of outperforming the passive noninvasive 
counterpart in estimating central aortic BP and radial blood pressure as a 
surrogate to central BP.  
 
5.2: Anticipated Benefits and Contributions 
 
It is anticipated that the findings of this thesis will be foundations for developing 
further cardiovascular health monitoring techniques. The ITF methodology can be 
utilized in certain operations or conditions to continuously monitor the central aortic 
blood pressure and assist in diagnosis of cardiovascular disease based not only on 
systolic and diastolic blood pressures but also making use of waveform morphology. 
The active noninvasive system identification methodology can potentially be 
developed into a commercial device easily used in common medical services centers 
and also possibly at home. This methodology encompasses several key necessities of 
all technologies that want to make their way into the modern commercial devices age, 
i.e. that they must be relatively cheap, noninvasive and easily usable. The active 
noninvasive methodology utilizes blood pressure cuffs which are familiar to patients 
and also cheap and the mathematics can be encoded onto a microchip, making it 
easily accessible and easy to use for users. 
The multichannel blind system identification approach applied to the tube-load model 
can further be exploited and applied to other systems with multiple measurable and 
distinct end-points, for just 1 example one can consider the diabetes problem where 
phosphor and glucose levels can be measured independently and the multichannel 
blind system identification methodology can be applied to estimate the amount of 
insulin in the plasma of the subject. 
 
5.3: Future Directions 
In this study a preliminary methodology for noninvasive active system identification 
of the arterial tree was introduced and it was demonstrated that the methodology can 
estimate the central aortic blood pressure accurately. It is anticipated that to build on 
this preliminary study the following steps can be taken to realize a fully experimental 




1. Validation of the external excitation wave propagation phenomena: 
In this study the external excitation provided to the arterial tree through the 
collocated actuator sensor system is assumed to propagate through the tube 
that it is applied in a lossless manner. In future studies building on this work 
externally applied excitations should be tested in practice to demonstrate the 
propagation of the excitations through the arterial tree. One possible way is to 
apply two thigh cuffs or a thigh and arm cuff, apply an external excitation at 
one thigh cuff and pick-up the resulting propagated external excitations in the 
opposing cuff. Other possibilities include performing the same maneuver with 
the cuff and pick-up the oscillations utilizing a tonometer. This step is 
important due to the propagation of the externally produced excitations being 
a key component to producing rich transmural blood pressures to produce 
accurate and reliable estimates of the parameters characterizing the arterial 
tree. It is noted that in this thesis the data utilized for the feasibility study was 
an amalgamation on invasively measured data and artificially produced data. 
  
2. Validation of the noninvasive blood pressure measurements: 
In this study the peripheral blood pressures are estimated through a protocol 
outlined in chapter 4. The feasibility of this protocol was demonstrated 
utilizing a complex and previously validated model of the cuff, tissue and 
hemodynamics model. Further experimental validation of this protocol is 
required to prove the feasibility of the active noninvasive system identification 
methodology. Possible methodologies for the validation of the noninvasive 
blood pressure protocol can be to simultaneously measure arterial blood 
pressure and cuff oscillations at the same location and validate viscoelastic 
models or to measure cuff oscillations at the brachial artery and utilizing a 
viscoelastic model of the artery, tissue and cuff along with a tube-load model, 
relate this measured cuff oscillation signal to a blood pressure signal measured 
at the finger location. 
 
3. Fully experimental validation of the active noninvasive system identification 
methodology: 
In order to fully realize the active noninvasive system identification 
methodology experimentally the collocated actuator and sensor system needs 
to be attached to a subject and invasive measurements of the central aortic 
blood pressure along with the rich transmural blood pressures created by the 
actuator need to be recorded simultaneously. Once the protocol is 
implemented and an estimate of the central aortic blood pressure is created, it 
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will be compared to the measured counterpart to evaluate its accuracy this will 
serve as a criteria in order to evaluate the effectiveness of the active 
noninvasive system identification methodology. The active methodology can 
be compared to a passive counterpart by removing the excitation and utilizing 
the criteria in order to ensure a more accurate estimation can be made by the 
active methodology. Finally if peripheral passive invasive signals are 
available previously developed ITF methodology can be utilized to estimate 
central aortic blood pressure and compare this methodology with the active 
noninvasive methodology to evaluate which is more accurate. 
 
4. Extension of the arterial tree model to account for losses in the arterial tree 
In the active noninvasive methodology developed in this thesis, the arterial 
tree was modeled by an asymmetric 2 tube-load model and the tube-load 
models were assumed to be lossless. It has previously been demonstrated that 
the tube-load model in its lossless form is an accurate and reliable model 
estimating the wave propagation and hemodynamics of the human arterial tree 
[59]. Investigating the effects of incorporating losses in the tube-load model 
and its potential impact on the performance of the active noninvasive 
methodology would be of importance for further developing a model based 
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